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Tumor Suppressor Candidate 2 (TUSC2) is a novel tumor suppressor gene located in 
the human chromosome 3p21.3 region. TUSC2 mRNA transcripts could be detected on 
Northern blots in both normal lung and some lung cancer cell lines, but no endogenous 
TUSC2 protein could be detected in a majority of lung cancer cell lines. Mechanisms 
regulating TUSC2 protein expression and its inactivation in primary lung cancer cells are 
largely unknown.  We investigated the role of the 5’- and 3’-untranslated regions (UTRs) 
of the TUSC2 gene in the regulation of TUSC2 protein expression. We found that two 
small upstream open-reading frames (uORFs) in the 5’UTR of TUSC2 could markedly 
inhibit the translational initiation of TUSC2 protein by interfering with the “scanning” of 
the ribosome initiation complexes. Site-specific stem-loop array reverse transcription-
polymerase chain reaction (SLA-RT-PCR) verified several micoRNAs (miRNAs) 
targeted at 3’UTR and directed TUSC2 cleavage and degradation.   
      In addition, we used the established let-7-targeted high mobility group A2 (Hmga2) 
mRNA as a model system to study the mechanism of regulation of target mRNA by 
miRNAs in mammalian cells under physiological conditions. There have been no 
evidence of direct link between mRNA downregulation and mRNA cleavages mediated 
by miRNAs. Here we showed that the endonucleolytic cleavages on mRNAs were 
vii 
 
initiated by mammalian miRNA in seed pairing style. Let-7 directed cleavage activities 
among the eight predicted potential target sites have varied efficiency, which are 
influenced by the positional and the structural contexts in the UTR. The 5’ cleaved RNA 
fragments were mostly oligouridylated at their 3’-termini and accumulated for delayed 
5’–3’ degradation. RNA fragment oligouridylation played important roles in marking 
RNA fragments for delayed bulk degradation and in converting RNA degradation mode 
from 3’–5’ to 5’–3’ with cooperative efforts from both endonucleolytic and non-catalytic 
miRNA-induced silencing complex (miRISC). Our findings point to a mammalian 
miRNA-mediated mechanism for the regulation of mRNA that miRNA can decrease 
target mRNA through target mRNA cleavage and uridine addition.  
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Chapter 1. Overview  
RNAs are divided into two classes: messenger RNAs (mRNAs), which are translated 
into proteins, and non-coding RNAs (ncRNAs), which does not encode protein. 
However, this does not mean that such ncRNAs do not contain information nor have 
function. Although it has been traditionally thought that most important genetic 
information is translated to proteins, recent evidence suggests that the majority of the 
genomes is transcribed into ncRNAs. The total fraction of protein-coding transcripts is 
about 1.4% in humans, whereas about 27% is transcribed as introns and UTRs 
(untranslated regions) but not translated [1, 2], which further increase the space for 
potential novel ncRNAs.  
Most genomic DNA can be regulated at either the transcriptional level, controlling 
whether a gene is transcribed or not, or at the post-transcriptional level, controlling the 
fate of the transcribed RNA molecules, including their stability, the efficiency of their 
translation and their subcellular localization. The past few years have seen a rapid 
expansion in the identification and characterization of mRNA regulatory elements in 
UTRs.   
1.1 Post-transcriptional regulation of gene expression in UTRs of mRNA  
UTRs play crucial roles in the post-transcriptional regulation of gene expression, 
which control mRNA stability [3], translation efficiency [4], and subcellular localization 
[5]. The turnover of mRNAs is a crucial step in post-transcriptional regulation of gene 
expression. The rate of mRNA synthesis is not the sole determinant of mRNA, and the 
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mRNA decay rate is also a major determinant. Several mechanisms have been proposed 
to describe how mRNA degradation takes place: decay can be preceded by shortening or 
removal of the poly (A) tail at the 3' end or by removal of the m7G cap at the 5' end [6]. 
The turnover of an mRNA is widely regulated by cis-acting elements located in the 3' 
UTR, such as the AU-rich elements (AREs), which promote mRNA decay in response to 
cell signals. Degradation of mRNAs can also take place by endonuclease activity. 
Endonucleolytic cleavage has been identified in the 3' UTR region which is targeted by 
miRNAs. It has been recently reported that let-7 miRNA results in degradation of lin-41 
target mRNA in C. elegans [7].  
     UTRs have a fundamental role in the control of RNA subcellular location, which is 
particularly important during organism development. In many cases, mRNAs are 
localized as ribonucleoprotein complexes along with proteins of the translational 
apparatus, thus ensuring efficient localized translation. One example is 21-nucleotide 
element in the 3' UTR of MBP mRNA, which are required for MBP mRNA transport and 
localization [8]. 
    In addition, UTRs play an important role in controlling mRNA translation efficiency, 
in which 5’ UTR play a major role. Several cis-acting elements within 5’UTR, such as 
upstream ORFs (uORFs), secondary structures or binding by specific proteins could be 
involved in translation efficiency regulation. Recently, it was demonstrated that uORFs 
reduce protein translation initiation levels by 30-80 %. After translation of the uORFs, 
the large (60S) ribosomal subunit will be detached and the 40S small ribosomal subunit 
may resume scanning, reinitiating with impaired translation efficiency of the main ORF. 
An example has been reported for the yeast transcription factors GCN4 and YAP1 down-
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regulation by uORFs [9]. Another alternative mechanism for translation initiation, which 
allows translation of the RNAs in a cap-independent manner, is an internal ribosome 
entry site (IRES). Cell may use IRES to increase translation of certain proteins during 
mitosis. In mitosis, the cell dephosphorylates eIF-4E so that it has little affinity for the 
5'cap. As a result, the pre-initiation mRNA loop is not formed, and the translational 
machinery is diverted to IRES within the mRNA. Many proteins involved in mitosis are 
encoded by IRES mRNA.  
1.2 Biogenesis and Functions of miRNA  
    miRNAs are small ncRNAs that have been shown to function as key regulators of gene 
expression and modulate many crucial biological processes, such as cell proliferation, 
differentiation, and apoptosis in multicellular organisms [12-14].  miRNA genes are 
transcribed as long primary microRNA (pri-miRNA), which is processed by Drosha and 
its co-factor DGCR8 to generate precursor miRNA (pre-miRNA). Pre-miRNA is rapidly 
exported to the cytoplasm by exportin-5 in a Ran–GTP-dependent manner, where it is cut 
by Dicer to generate a mature approximately ~22 nucleotides long miRNA [10, 11]. 
Mature miRNAs are incorporated into argonaute proteins as guide sequence in the 
assembling of miRNA-induced silencing complex (miRISC) for target-specific gene 
silencing [15].  
     Small RNA Lin-4 was first reported miRNA as gene regulatory molecule in 1993 [16]. 
Plant miRNAs match their mRNA target complementarily to ensure irreversible cleavage 
of target mRNAs and this is thought to be the predominant mode of miRNA mechanism 
in plants [17]. In mammalian cells, miRNA: target pairing are rare and miRNA 
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recognizes mRNA targets with much shorter base pairs usually located at highly 
conserved nucleotides at position 2 -7 of miRNA 5’ termini [18]. In mammalian cells, the 
mechanistic details for miRNAs in repressing protein synthesis are still poorly 
understood. miRNAs can affect both the translation and stability of mRNAs, but the 
results from studies conducted in different laboratories have often been contradictory. 
Earlier studies suggest that the miRNA-induced gene expression interference is through 
binding to the 3’UTR of target mRNA and repressing translation. Recent studies suggest 
that the mammalian miRNAs predominantly act to decrease target mRNA levels. 
However, no direct evidence for miRNA-mediated target mRNA cleavage and 
degradation has been demonstrated in mammalian cells [19]. The detection methods used 
in those studies, i.e., 5’-RACE, PARE, Ribosome profiling, lacked the necessary 
sensitivity to address the short lived nature of mRNA intermediates in detail especially 
when there were only small portion of mRNA cleavages. With improved detecting 
methods, those few cases of miRNA cleavages could just be the tip of iceberg.  
     Animal AGO proteins are essential for miRNA-directed target mRNA destabilization, 
but insufficient for silencing. The study of the mechanism of miRNA-mediated mRNA 
destabilization has been demonstrated in D. melanogaster. P‑body protein GW182, 
which interacts with the miRNP Argonaute1, is a key factor that marks mRNAs for decay 
[20, 21].  
   The CCR4-NOT complex and PAN2-PAN3 complex are two major enzyme complex, 
which are responsible for mRNA deadenylation. Depletion of CCR4–NOT complex 
prevents the decay-promoting activity of GW182, suggesting that GW182 plays a role in 
recruiting CCR4–NOT to destabilize mRNAs [22]. It has also been reported that GW182 
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recruits the PAN2-PAN3 deadenylase complex through PAM2 motif [23].  In addition, 
accelerated deadenylation results in a miRNA-induced degraded mRNAs in mammalian 
cells. Widespread miRNA-mediated deadenylation of mRNAs occurs during zebrafish 
embryogenesis, in which miR‑430 facilitates the destabilization of hundreds of mRNAs 
by inducing their deadenylation and subsequent decay at the onset of zygotic 
transcription [24, 25].         
 
1.3 Roles of non-coding RNAs in Regulation of Gene expression  
 
 
    There are some other ncRNAs, which play important roles in cells. piRNAs (PIWI-
interacting RNAs) are ncRNAs of 24–30 nt in length, binding the PIWI subfamily of 
AGO proteins that are involved in target RNA repression. The complex, formed by 
piRNAs and PIWI proteins, suppresses transposable element expression and 
mobilization. snoRNAs (small nucleolar RNAs)  are 60–300 nt in length ncRNAs, which 
guide the site-specific modification of nucleotides in target RNAs through short regions 
of base-pairing. SnoRNAs are composed of two major classes, the box C/D snoRNAs 
which guide 2’-O-ribose-methylation, and the box H/ACA snoRNAs which guide 
pseudouridylation of target RNAs [26, 27].  
There is still considerable debate as to whether ncRNAs are functional or merely some 
kind of ‘transcriptional noise’. It appears that the human genome express an enormous 
repertoire of ncRNAs, which had been previously overlooked. We may have 
fundamentally misunderstood the nature of genetic programming. Although the functions 
of these ncRNAs are likely to be varied, the evidences strongly suggest that their main 
role is to regulate and direct the complex pathways in cells [28].The extent of ncRNAs 
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conservation is also much higher than mRNAs, perhaps as high as 10% [29]. This 
conservation includes ultra-conserved sequences [30] and long transposon-free regions 
that have remained refractory to transposon insertions during evolution [31]. There are 
probably many other functions of ncRNAs awaiting discovery. For example, the 
observation that many ncRNAs are located in the cytoplasm suggests that they might 
have undiscovered roles. There is increasing interest in the potential involvement of 
ncRNAs in disease development, owing to aberrant function of ncRNAs in differentiation 
and developmental processes. For example, an antisense ncRNA transcribed from the p15 
tumor suppressor locus regulate local heterochromatin and DNA methylation status, 
thereby down-regulating p15 expression, which is involved in oncogenesis in leukemia 
[40].  
1.4 Therapeutic Applications of miRNAs and miRNA-target Sites in Human 
Cancers 
    miRNA is the most widely studied group of ncRNAs in human cancer. miRNA 
expression profiles differ between normal cells and tumor cells, acting as oncogenes or 
tumor suppressors [41]. One of the first reported associations between miRNAs and 
cancer was miR‑15 and miR‑16 dysregulation in most B cell chronic lymphocytic 
leukaemias as a result of chromosome 13q14 deletion [42]. Another intriguing example is 
miR-200. CpG island hypermethylation-associated silencing of miR-200 in tumors up-
regulate the zinc finger E-box-binding homeobox ZEB1 and ZEB2, which, in turn, leads 
to a down-regulation of E-cadherin, promoting epithelial-to-mesenchymal transition 
(EMT) in cancer [43].  
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Antisense oligonucleotides (ASOs) are therapeutically widely used to inhibit miRNA 
function. ASOs inhibit miRNA targets based on base-pair complementarity. There are 
three main classes of ASOs, including locked nucleic acids (LNAs), anti-miRNA 
oligonucleotides (AMOs) and antagomirs with chemical modifications to increase 
stability and efficacy [44]. For example, the intravenous injection of antagomirs targeting 
miR-10b prevents the onset of metastasis, suppressing dissemination to the lungs in the 
mouse [45].  Another recent study reported the use of ‘miRNA replacement therapy’ 
strategy, restoring miR-26a expression in hepatocellular carcinoma. miR-26a was 
delivered by an adenoviral vector in a mouse model of hepatocellular carcinoma, 
resulting in suppression of proliferation and induction of apoptosis, thereby inhibiting 
cancer progression [46]. 
In addition, certain features in UTR have been approved to be associated with tumor 
genesis. BRCA1 (breast cancer 1) acts as a tumor suppressor and is involved in cell-cycle 
checkpoints, apoptosis and DNA damage repair. BRCA1 protein expression is controlled 
by an alternative 5’ UTR. BRCA1 has two promoters (α and β), encoding two 5’ UTR 
differing in the length of the 5’UTR.The longer 5’UTR is found in breast cancer tissues, 
whereas the shorter 5’UTR is found in normal breast tissues. The longer 5’UTR, being 
more structured and having additional uAUGs, is translated 10-fold less efficiently than 
the shorter 5’UTR. Thus BRCA1 expression is inhibited in breast cancers by longer 
5’UTR. Therefore, BRCA1 promoter α (producing longer 5’UTR) can be an effective 
target in breast cancer therapy [47]. 
There are many well characterized examples of UTRs that act as regulatory ncRNAs in 
disease development. Another intriguing example is the ncRNA HSR1 (heat-shock RNA-
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1), which forms a complex with HSF1 (heat-shock transcription factor 1), enabling the 
transcription factor to induce expression of heat-shock proteins during the cellular heat-
shock response [23]. UTRs are the sensors of miRNAs by base-pairing mechanism. For 
instance, SLITRK1 mRNA 3’UTR sequence variants in the binding site for the miR-189 
have been shown to be associated with Tourette’s syndrome. 
1.4 The purpose of this study  
Interests in the contribution of ncRNAs to the genesis and progression of human 
disorders are booming. However, there are still huge gaps in our study of ncRNAs, 
including their function and mechanisms by which ncRNAs exert pathological effects. It 
will be crucial to understand the mechanism how miRNA regulation of target mRNA 
repression, which is the basis to miRNA research in mammalian cells.  
    One important challenge will be to identify all functional ncRNAs that are encoded in 
the human genome. What is required, and is currently developing, is the application of 
unbiased techniques, such as the Encyclopedia of DNA Elements (ENCODE) project, 
which will identify all functional elements in the human genome [48]. Bioinformatics 
tools for identifying potentially functional ncRNAs will also be important. Because 
ncRNAs fold into complex secondary structures that are crucial to their function, 
sequence-based alignments alone might not be enough to identify ncRNAs. A number of 
algorithms have been developed to identify potentially functional ncRNAs (for example, 
RNAfold, Pfold, CMFinder and Foldalign). To some degree, the studies of ncRNAs have 
been delayed, which is because of the lack of appropriate laborious techniques to identify 
these ncRNAs systematically. Identification of novel ncRNA occurred rather by chance 
than by systematic screens. 
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      With respect to disease, understanding the precise biological roles of ncRNAs is a key 
challenge. For example, mouse model is a good model to study the specific function of 
ncRNAs. A recent study of mouse model that conditionally express miR-21, revealed that 
miR-21 as a genuine oncogenes [49]. Biochemical tools, such as antagomirs, have been 
useful in elucidating the function of miRNAs, however, having its limitations. Some 
other techniques have been developed, for example, rapid amplification of cDNA ends 
(RACE) method was used to define the origin of transcription of T-UCRs, but the process 
is very time consuming [50]. Therefore, advanced molecular biological and biochemical 
tools and methods are much needed to efficiently and accurately identify non-coding 
region RNA. Technical breakthroughs can bridge the gap between ncRNAs knowledge 
and knowledge-based application in disease diagnosis and treatment.  
     In our study, we tried to study the transcriptional regulation of TUSC2. TUSC2 is a 
novel tumor suppressor gene located in the human chromosome 3p21.3 region. TUSC2 
mRNA transcripts could be detected on Northern blots in both normal lung and some 
lung cancer cell lines, but no endogenous TUSC2 protein could be detected in a majority 
of lung cancer cell lines. Mechanisms regulating TUSC2 protein expression and its 
inactivation in primary lung cancer cells are largely unknown. We investigated the role of 
the 5’-UTR and 3’-UTR of the TUSC2 gene in the regulation of TUSC2 protein 
expression, as TUSC2 have very conservative and complex UTRs. We found that two 
small uORFs in the 5’UTR of TUSC2 could markedly inhibit the translational initiation 
of TUSC2 protein by interfering with the “scanning” of the ribosome initiation 
complexes. In addition, there are miR-98, miR-93 and miR-197 directed cleavage sites on 
TUSC2 3’TUR, which cause TUSC2 mRNA degradation.   
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      In addition, we tried to study the mechanistic details for miRNAs in repressing 
protein synthesis. The established let-7 miRNA -targeted Hmga2 mRNA was used as a 
model system to study the regulation of target mRNA by miRNAs in mammalian cells 
under physiological conditions. In our study, we pointed out a direct link between mRNA 
down-regulation and mRNA cleavages mediated by miRNAs, which were confused in 
many years regarding miRNA mechanism study. The endonucleolytic cleavages on 
Hmga2 target mRNAs were initiated by let-7 miRNA in seed pairing style have been 
detected by our new developed SLA-RT-PCR. After that, the 5’ cleaved RNA fragments 
were mostly oligouridylated at their 3’-termini and destroyed by mRNA 5’–3’ 
degradation. These findings warrant further investigation to identify the precise miRNA 
targets in mammalians in endogenous context.  
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Chapter 2. Regulation of Novel Tumor Suppressor Gene TUSC2 Expression in 
Human Lung Cancer Cells 
2.1 Introduction  
2.1.1 Lung Cancer and tumor suppressor gene  
      Lung cancer is the most common cancer in the world, with an estimate of 1.35 
million new cases per year. Lung cancer kills more than 1.18 million patients each year, 
as the leading cause of cancer death for both men and women. More than 85 % of lung 
cancers are caused by tobacco smoke [51-53]. Studies of lung cancers have shown that 
genetic alterations in the short arm of chromosome 3p are among the most frequent and 
earliest genomic abnormalities. Moreover, the 3p21.3 region has been frequently detected 
in smoke-damaged pre-neoplastic lesions. These findings suggest that one or more genes 
in 3p21.3 region are tumor suppressor genes as molecular gatekeepers in lung cancers. 
TUSC2 gene, also called FUS1, is one candidate tumor suppressor gene, located in 
3p21.3 region [54-55]. Wild-type TUSC2 protein induces tumor cells G1 growth arrest 
and apoptosis, suppresses tumor growth and inhibits lung metastases in mouse model. 
TUSC2 induces apoptosis through the activation of the mitochondria-dependent and 
Apaf-1 associated pathways and inhibits the tyrosine kinases function including EGFR, 
PDGFR and AKT [56-60]. Enforced expression of TUSC2 in H1299 cells inactivated c-
Abl and its tyrosine kinase [61]. It also showed that expression of TUSC2 sensitized the 
response of lung cancer cells to cisplatin, which was associated with the down-regulation 
of MDM2 and increase of p53 [62].  
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       Squamous metaplasia and dysplasia express significantly lower levels of TUSC2 
than normal and hyperplastic bronchial epithelia. Loss or reduction of TUSC2 protein 
expression is associated with worse overall patient survival [60]. TUSC2-nanoparticles is 
used in Phase I clinical trial for patients with chemotherapy refractory stage IV lung 
cancers at the University of Texas M.D. Anderson Cancer Center. TUSC2 mRNA 
transcripts could be detected on Northern blots in both normal lung and some lung cancer 
cell lines, but no endogenous TUSC2 protein could be detected in a majority of lung 
cancer cell lines. Only a few mutations in TUSC2 gene are found in human lung cancers, 
and its promoter methylation is a rare phenomenon. Uno et al. showed TUSC2 is a 
myristoylated protein and loss of myristoylation at the N-terminus cause TUSC2 protein 
rapidly degradation. The defect of the TUSC2 protein was detected in primary lung 
cancers [58]. However, mechanisms regulating TUSC2 protein expression and its 
inactivation in lung cancers are largely unknown. Therefore, elucidation of mechanisms 
regulating TUSC2 protein expression is important to control the loss of TUSC2 in the 
early pathogenesis of lung cancer. 
 
2.1.2 TUSC2 protein expression regulation  
       The regulatory events that govern gene expression are implemented at three levels: 
transcription, post-transcription, and translation. The normal TUSC2 mRNA expression 
in tumor cells suggests translational control of TUSC2 mRNA might inactivate TUSC2. 
Although many features of mRNA can contribute to its translation, control elements are 
mostly found in the un-translated regions of transcripts (UTRs), because UTRs are under 
less pressure of sequence conservation and easily to form regulatory elements [63]. It is 
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widely known that 5’UTR is responsible for translation initiation through start-site 
consensus sequence as well as upstream AUGs [64]. 3’UTR regulates transcripts stability 
and localization, which contains numerous binding sites for regulatory factors [65]. A 
highly conserved and long complex TUSC2 UTRs suggests UTRs might play an 
important role in regulation of TUSC2 protein expression. Here, we investigated the role 
of the TUSC2 UTRs in the regulation of TUSC2 protein expression and detected the 
regulatory mechanisms lead to the loss or reduction of TUSC2 expression in lung cancer 
cell lines.  
 
2.2 Methods and Materials 
2.2.1 Cell lines and cell cultures 
     The human non-small cell lung cancer cell (NSCLC) line H1299, A549, H322 and 
cervix Hela cells were obtained from American Type Culture Collection. H1299, A549, 
H322 and Hela cells were grown in RPMI 1640 supplemented with 10% fetal bovine 
serum in an atmosphere of humidified air containing 5% CO2.  Normal human bronchial 
epithelial (HBE) cells were obtained from Dr. John Minna’s laboratory. HBE cells were 
grown in Keratinocyte-SFM medium (Invitrogen, Carlsbad, CA).   
 
2.2.2 Preparation of plasmids  
      A 1772 nucleotides sequence region containing TUSC2 coding region bounded by 
5’UTR and 3’UTR was cloned into pKGB2 plasmid. Following the same construction 
procedure, 433 nucleotides (nts) 5’UTR-TUSC2 coding region, 1672 nts TUSC2 coding 
region-3’UTR, 333 nts TUSC2 was cloned into each pKGB2 construct. We constructed 
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four plasmids with the same backbone and different translated regions as follows: 
5’UTR-TUSC2-3’UTR, 5’UTR-TUSC2, TUSC2-3’UTR and TUSC2. Figure 1 showed 
schematic drawing of the four plasmids. All constructs were confirmed by DNA 
sequencing.  
 
 
Figure 1. Effects of UTRs of TUSC2 mRNA gene and protein expression in human 
NSCLC H1299 and normal HBE cells. Schematic representations of TUSC2 expressing 
constructs with or without intrinsic 5’UTR and 3’UTR. TUSC2 expression plasmid 
constructs contain an expression cassette with a CMV promoter-FUS1 CDS-BGH polyA 
signal (Reproduced with permission of BBRC 410(2):235-241). 
 
2.2.3 Plasmid transfection 
      Cells were plated and cultured overnight, and then transfected with specified 
expression vectors using DOTAP: cholesterol - encapsulated plasmid DNA nanoparticles. 
In brief, 2 µL DOTAP: cholesterol reagent and 2 µg plasmid DNA were mixed, and the 
mixture was added to each well in a six-well plate and incubated for indicated days. The 
transfection efficiency was assessed by a parallel transfection with an equal amount of 
green fluorescent protein (GFP)-expressing plasmid vector. 
 
2.2.4 RNA isolation 
      For total RNA preparation, cells were grown on 6-well plates and approximately 2 x 
106 cells were used to isolate the total RNA using the TRIzol reagent (Life Technologies, 
FUS1-CDS Poly ACMVFUS1
5’ UTRCMV Poly A5’UTR-FUS1 FUS1-CDS
CMV 3’ UTR Poly AFUS1-3’UTR FUS1 CDS
CMV 5’ UTR 3’ UTR Poly A5’UTR-FUS1-3’UTR FUS1-CDS
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Grand Island, NY) and phenol:chloroform extraction and ethanol precipitation according 
to the manufacturer’s protocol. The isolated total RNA was stored in 70% ethanol at -
80C.  
 
2.2.5 Reverse-transcription and quantitative Real-time PCR 
      RNeasy Mini kit was used to isolate total RNA. RNA was treated with DNase I and 
was reverse-transcribed using High Capacity cDNA Reverse Transcription Kit. 
Quantitative real-time PCR was performed in triplicate for each reaction. Negative 
control group using samples without reverse-transcribed was used to see if there is any 
DNA contaminated in RNA isolation. Melting curve analysis confirmed a single PCR 
product in each reaction. The nucleotide sequence of the primers as follows:  
TUSC2 sense primer: 5’-TCAGAGGCAGCAGGAGCTGA-3’, TUSC2 anti-sense primer 
:5’-CATAGAACATAGAGCCGCGG.  
GAPDH sense primer: 5’-TGCACCACCAACTGCTTAGC-3’, GAPDH anti-sense 
primer: 5’-GGCATGGACTGTGGTCATGAG.   
GFP sense primer: 5’-TGAGCAAGGGCGAGGAGCTGTT-3’, GFP anti-sense primer: 
5’- CACGCTGAACTTGTGGCCGT-3’.  
 
2.2.6 Western blotting assay 
    Cell lysates were prepared by incubating cells in lamin/urea buffer on ice, and 
centrifuged at 13,000 rpm for 10 min at 4°C. 50 μg cell lysate of each treatment were 
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resolved by SDS-PAGE and transferred onto a polyvinylidene difluoride membrane. 
TUSC2 protein was detected with rabbit anti-TUSC2 antibody. The following 
monoclonal antibodies were used: anti-green fluorescent protein (GFP) antibody and anti- 
β-actin antibody (Clontech, CA).  
 
2.2.7 Secondary structure prediction of RNA segments 
     The lowest free-energy secondary structure for TUSC2 RNA was predicted by 
RNAfold software (www.tbi.unvivie.ac.at). 
 
2.3 Results 
2.3.1 Expression of TUSC2 is repressed by its UTR 
     To determine the UTR regulation for TUSC2 expression, we transfected H1299 cells 
and HBE-KTR cells with four plasmids, which have the same backbone and different 
translated region including TUSC2, 5’UTR-TUSC2, TUSC2-3’UTR, 5’UTR-TUSC2-
3’UTR. In H1299 and HBE-KTR cell, UTRs down-regulate TUSC2 mRNA expression 
significantly (P<0.05). In H1299 cell, compared with the transcripts from construct only 
carrying TUSC2 coding sequence, the TUSC2 transcript level decreased significantly 3-
fold from 5’UTR-TUSC2 construct (P<0.05) and decreased significantly 10-fold from 
TUSC2-3’UTR construct (P<0.05). In HBE-KTR cell, the TUSC2 transcript level 
decreased about 2-fold from 5’UTR-TUSC2 construct and decreased significantly 4-fold 
from TUSC2-3’UTR construct (P<0.05) (Figure 2). These observations indicated that 
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5’UTR and 3’UTR decreased the abundance of TUSC2 transcripts, which was more 
significant in tumor cells than in normal cells.  
 
Figure 2. Effects of UTR of TUSC2 mRNA gene expression in human NSCLC H1299 
and normal HBE cells. Real-time PCR analysis for effects of TUSC2 5’- and 3’-UTR on 
the TUSC2 mRNA expression in HBE and H1299 cells. In both cases the TUSC2 RNA 
expression for cells transfected with TUSC2 expression plasmid without UTR was set to 
1. TUSC2 relative gene expressions were normalized to GFP levels. * means P< 0.05, 
error bars denote standard error. (Reproduced with permission of BBRC 410(2):235-241) 
 
     After 48h transient transfection, the western blot results showed that both 5’UTR and 
3’UTR down-regulated TUSC2 protein expression. 3’UTR inhibitory effect showed more 
significant in tumor cell line H1299 than in normal cell line HBE-KTR, which is 
correlated with mRNA transcripts changes regulated by 3’UTR (Figure 3). A band close 
to molecular weight of TUSC2 was observed, however, this is a nonspecific band as it 
was detected in H1299 which cannot express TUSC2. Thus studies using this TUSC2 
antibody should be interpreted with caution.  
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Figure 3. Effects of UTRs on FUS1 protein expression in H1299 and HBE cells by 
Western-blot analysis. Western blotting analysis for TUSC2 protein expression in HBE 
and H1299 cells transfected with TUSC2 expression plasmids with or without UTRs. 
(Reproduced with permission of BBRC 410(2):235-241) 
  
     To further confirm these findings, we investigated whether the TUSC2 UTRs exert a 
similar effect on the translation of GFP. We cloned TUSC2 5’UTR and 3’UTR into GFP 
reporter plasmid to test regulation of TUSC2 UTRs on GFP translation. H1299 cells were 
transiently co-transfected with the plasmids carrying GFP coding region with or without 
TUSC2 UTRs and CMV promoter-RFP plasmid. CMV promoter-RFP plasmid was 
added to test if plasmid transfection efficiency was the same in these two groups. 48 h 
later, the presence of TUSC2 UTRs significantly inhibited GFP expression, confirming 
that TUSC2 UTRs have sequence or secondary structure element inhibition on gene 
translation (Figure 4).  
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Figure 4. Repression of reporter GFP protein expression by FUS1 UTRs in H1299 cells. 
(A) H1299 cells were co-transfected with either a CMV-GFP [a] or a CMV-5’UTR-GFP-
3’UTR [b] expression plasmid, together with a CMV-RFP expression plasmid, to 
normalize GFP expression in these H1299 transfectants. GFP [a and b] and RFP [c and d] 
protein expressions were visualized under a fluorescence microscope. (B) Quantification 
of GFP expression in CMV-GFP and CMV-5’UTR-GFP transfectants, which was based 
on RFP expression as transfection control. (Reproduced with permission of BBRC 
410(2):235-241) 
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2.3.2 TUSC2 translation is repressed by 5’UTR 
      TUSC2 5’UTR contains two small uORFs encoding an 8-amino-acid peptide 
(uORF1) and another 6-amino-acid peptide (uORF2), which could inhibit the main ORF 
translation initiation by interfering with the “scanning” of the ribosome subunit. 
Therefore, we made three site-directed point mutation plasmids in 5’UTR-TUSC2 to 
detect the funtction for these two uORF: the first plasmid is to mutate the first ATG to 
AAG in uORF1 for eliminating uORF1; the second plasmid is to mutate the second ATG 
to AAG in uORF2 for eliminating uORF2; the third plasmid is to mutate both ATG to 
AAG in two uORFs for eliminating both uORFs (Figure 5).  
 
 
 
Figure 5. Regulation of TUSC2 5’UTR on FUS1 expression. Schematic representation of 
TUSC2 expressing constructs with 5’UTR site-directed eliminations of uORFs. The 
positions of the uORFs and their corresponding point-mutation constructs are indicated 
by arrows. (Reproduced with permission of BBRC 410(2):235-241)  
 
     We transfected these plasmids into H1299 cells and HBE-KTR cells. Mutation of 
uORFs significantly abolished the 5’UTR down-regulation function in TUSC2 protein 
expression but not in mRNA transcripts, which suggests these two uORFs inhibit TUSC2 
gttt---gcaggttatggtagtgcggactgcggtgtgagcagagcggccacggggcccgccatgcgccggcggccctgacATG------
5’UTR 
start uORF1 uORF2
FUS1 Translation 
start site
gttt---gcaggttaaggtagtgcggactgcggtgtgagcagagcggccacggggcccgccatgcgccggcggccctgacATG------
Mut-uORF1 uORF2
gttt---gcaggttatggtagtgcggactgcggtgtgagcagagcggccacggggcccgccaagcgccggcggccctgacATG------
uORF1 Mut-uORF2
gttt---gcaggttaaggtagtgcggactgcggtgtgagcagagcggccacggggcccgccaagcgccggcggccctgacATG------
Mut-uORF1 Mut-uORF2
Wt-FUS1 
mRNA
Mut-uORF1
(mt1)
Mut-uORF2
(mt2)
Mut-uORF1-2
(2mts)
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expression through translational influence, but not transcriptional influence (Figure 6 and 
Figure 7). The two uORFs inhibitory effect is constant in normal cell line HBE-KTR and 
tumor cell line H1299, suggesting TUSC2 cannot express extensively in tumor and 
normal cells, otherwise excessive TUSC2 give rise to cell cycle arrest and apoptosis.  
 
Figure 6. Effects of uORFs in 5’UTR on TUSC2 protein expression in H1299 cell and 
HBE cell. Western blot analysis of TUSC2 protein expression in HBE and H1299 cells 
transfected with TUSC2 expression plasmids with or without uORFs (Reproduced with 
permission of BBRC 410(2):235-241). 
 
 
 
Figure 7. Effects of uORFs in 5’UTR on TUSC2 RNA expression in H1299 cell and 
HBE cell. * means P< 0.05, error bars denote standard error. Real-time PCR analysis of 
TUSC2 protein expression in HBE and H1299 cells transfected with TUSC2 expression 
plasmids with or without uORFs (Reproduced with permission of BBRC 410(2):235-
241). 
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2.3.3 3’UTR regulation of TUSC2 expression  
     To elucidate which region of 3’UTR down-regulate TUSC2 expression, we performed 
a series of deletion mutants of the 3’UTR. The mRNA structure prediction program 
RNAfold software revealed that there are several hairpin-like stem elements in 3’UTR 
with potential to form stable secondary structure. As shown in Figure 8, we deleted a 
series of stable secondary structure: 334-504 nt, 764-1479 nt, 776-1102 nt, 1080 -1461 nt, 
1183-1248 nt (Figure 8).  
 
 
Figure 8. Effects of 3’UTR regulatory elements on TUSC2 expression in NSCLC H1299 
and normal HBE cells. Constructs of deletion mutants of TUSC2 3’UTR. Names, relative 
locations, nucleotide sequence lengths, and putative regulatory 3’UTR sequence elements 
of the deletion mutants in TUSC2 3’UTR are schematically illustrated. (Reproduced with 
permission of BBRC 410(2):235-241) 
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Figure 9. TUSC2 3’UTR and mutants secondary structure analyzed by RNAfold 
software. (Reproduced with permission of BBRC 410(2):235-241) 
 
 
      
       Figure 9 indicated the 3’UTR secondary structure after a specific stem loop deletion. 
After transfection of TUSC2-3’UTR containing 764-1479 nucleotides deletions in H1299 
cell, TUSC2 protein expression was significantly increased, indicating that elements in 
764-1479 nt are important for TUSC2 translation inhibition (Figure  10).   
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Figure 10. Effects of the 3’UTR mutations on TUSC2 protein expression by western-blot 
analysis. Expression of GFP was used to normalize the transfection efficiency in H1299 
cells co-transfected with a GFP expression plasmid and individual FUS1-3’UTR deletion 
mutants. (Reproduced with permission of BBRC 410(2):235-241) 
 
     We also observed TUSC2 mRNA level was increased after 764-1479 nt deletion 
(Figure 11), which suggest 764-1479 nt affected TUSC2 mRNA expression. In addition, 
deletion of 1080 -1461 nt can also increase TUSC2 protein expression, which indicated 
that 1080 -1461 nt might have regulatory elements, contributing to 764-1479 nt inhibitory 
function. TUSC2 3’UTR in H1299 cell shows more significant inhibition on TUSC2 
expression than in HBE-KTR cell. Interestingly, Figure 10 showed removals of 764-1479 
nucleotides in 3’UTR abolishes TUSC2 protein expression inhibition and RNA synthesis 
inhibition by 3’ UTR in H1299 cell, but has no effect in HBE-KTR cell. This result 
suggests 3’UTR repress TUSC2 expression in H1299 through 764-1479 nucleotides, but 
has no effect in HBE-KTR cells (Figure 11). Thus we speculate that 764-1479 
nucleotides in 3’UTR might have unique regulatory elements in tumor cells, which 
contribute to reduction of TUSC2 protein expression in tumor cells compared to normal 
cells.   
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Figure 11. TUSC2 mRNA expression in H1299 and HBE cells transfected with TUSC2 
3’UTR deletion mutants. Real-time PCR analysis of TUSC2 protein expression in HBE 
and H1299 cells transfected with TUSC2 3’ UTR deletion plasmids. Effects of the 
deletion at position 764–1476 (mut4) in the FUS1 30UTR region on FUS1 mRNA 
transcription in the H1299 and HBE cells. * means P< 0.05, error bars denote standard 
error. (Reproduced with permission of BBRC 410(2):235-241) 
 
 
2.4 Discussion  
      Translation can be divided into three stages: initiation, elongation, and termination. 
5’UTR is responsible for initiation of translation, which is the primary target of 
translation regulation. Selection of the translation initiation site occurs via “scanning 
mechanism”, which postulates that the small ribosome subunit scans linearly from the 5’ 
end of the mRNA; stopping when the first AUG codon is reached and forming an 80S 
ribosome to start translation [66]. Several cis-acting elements within 5’UTR, such as 
CDS 3'UTR mut40.0
0.5
1.0
1.5
* *
HBEC
CDS 3'UTR mut40.0
0.5
1.0
1.5
*
H1299
Re
la
tiv
e 
ge
ne
 
ex
pr
es
si
on
26 
 
uORFs, secondary structures or binding motifs bound by specific RNA binding proteins 
could be involved in translational regulation. Recently, it was demonstrated that uORFs 
reduce protein levels by 30-80 %. The translation repression by uORFs is associated 
with: strong uAUG context, evolutionary conservation, increased distance from the cap, 
and multiple uORFs in the 5’UTR. The 5’UTR of TUSC2 contains two uORFs; both of 
the uORFs are nearly identical in mice, chimpanzee and humans, which suggests good 
reservation. In addition, the uAUG of uORFs are far from the cap; and the 1st uAUG is 
flanked by a guanine at position -3 and a guanine at position +4, and the 2nd uAUG is 
flanked by a guanine at position -3 and a cytosine at position +4, and thus is in ‘adequate’ 
consensus context for uORF translation initiation start [67]. In agreement with this 
prediction, the two uORFs influences significantly TUSC2 translation. Mutation of 
uAUGs to uAAGs significantly up-regulate TUSC2 translation.  
       In addition, it was reported that stable stem loops with a free energy of -30 to -61 
kcal/mol are sufficient to block ribosomal scanning in 5’UTR and therefore inhibit 
translation. Based on RNAfold analysis, TUSC2 5’UTR display highly stable secondary 
structure with the free energy of -72.18 kcal/mol, which might impede ribosome 
scanning. As shown in Figure 6, the inhibitory function of 5’UTR cannot be all 
attributable to uORFs. The 5’UTR stable secondary structure might contribute to the 
TUSC2 translation initiation through blocking ribosomal scanning.  
       3’UTR regulate gene expression through mRNA 3’end processing, sub-cellular 
localization and its stability. We also identified several regulatory elements or motifs in 
the 3’UTR region of TUSC2 transcripts by serial deletions and biological 
characterization of these 3’UTR deletion mutants in normal lung and lung cancer cells. It 
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was reported that 3’UTR is “a molecular hotspot for pathology”, if disrupted, leads to life 
threatening disease. TUSC2 has a highly conserved and long complex 3’UTR, suggesting 
3’UTR might play a critical role in regulating TUSC2 expression. However, TUSC2 
3’UTR lacks typical AU-rich elements, which are well-known targets for degradation. It 
was reported that RNA binding proteins are involved in translational control of certain 
gene by binding to secondary structure elements like stem loops in 3’UTR. Sequence 
analysis revealed TUSC2 3’UTR has a series of stable secondary structure might be 
involved in TUSC2 expression regulation. Our findings indicate that nucleotides 764-
1479 nt in 3’UTR are decisive in the control of TUSC2 RNA expression in tumor cells 
and normal cells. However, precise structural elements and mechanism of repressive 
action in 3’UTR remained to be clarified. The 3’UTR of TUSC2 has been shown to be a 
target of other miRNAs including miR-93, miR-98, and miR-197 [136]. Down-regulation 
of TUSC2 expression in both SCLC and NSCLC cell lines and primary tumors correlates 
with elevated miR-93 and miR-197 expression [136]. The predicted miR-98 targeting site 
is located in Δ334–504 region of 3’UTR. These results suggest that differentially 
expressed miRNAs may target the 3’UTR of TUSC2 mRNA and act as negative 
regulators of TUSC2 expression in lung cancers. 
      The results indicate that TUSC2 expression is tightly regulated. Because too much 
TUSC2 could lead cell death and too little TUSC2 could promote tumor formation, it is 
extremely important that TUSC2 expression needs to be strictly controlled. Firstly, for 
the 5’UTR, two uORFs inhibitory effect is constant in normal cell HBE-KTR and tumor 
cell H1299, suggesting TUSC2 cannot express extensively otherwise excessive TUSC2 
give rise to cell cycle arrest and apoptosis. Secondly, for the 3’UTR, the stem loops 
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down-regulate TUSC2 protein expression through affecting mRNA stability in H1299 
cells, but not in HBE cells, which is responsible for the low-expression of TUSC2 protein 
in tumor cells.  
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Chapter 3. Detection of intermediates and end products of microRNA processing in 
human cells by a novel Stem-loop Array RT-PCR 
3.1 Introduction  
3.1.1 microRNA biogenesis  
      MicroRNAs (miRNAs) are small non-coding RNAs that have been shown to function 
as key regulators of gene expression at the posttranscriptional level and modulate many 
crucial biological processes, such as cell proliferation, differentiation, and apoptosis in 
multicellular organisms [68-75].  MiRNA genes are transcribed as long primary 
microRNA (pri-miRNA), which is processed by Drosha and its co-factor DGCR8 to 
generate precursor miRNA (pre-miRNA). Pre-miRNA is rapidly exported to the 
cytoplasm by exportin-5 in a Ran–GTP-dependent manner, where it is cut by Dicer to 
generate a mature miRNA [73,76-79] . The processed miRNA species are the production 
of phased small RNA reads that consist of the most abundant form of the 22 nt-long 
mature miRNAs, the less abundant miRNA isoforms, and other miRNA gene transcript-
originated miRNA and transient miRNA sequences [76]. Despite the complex 
compositions of these small RNA reads, there should be little variation in the RNA ends 
corresponding to Drosha and Dicer processing sites and, in particular, it should have a 
nearly uniform position at the 5′ ends of the RNA reads and a unique 2-nt overhang at the 
3′ ends of miRNA duplexes [75]. An in depth analysis of tremendous amounts of these 
small RNA reads could provide an opportunity for miRNA gene discovery but also poses 
the big challenge in distinguishing authentic miRNAs from other types of small RNA 
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species and in quantifying the abundance and verifying the accurate sequence of a given 
mature miRNA species in living cells [76,80,81]. 
  
3.1.2 Current methods used for detection of miRNAs 
    A number of methods are employed for sequence determination and expression 
profiling of endogenous miRNAs. Cloning and Northern blotting are the standard 
methods for miRNA sequence analysis, but such approaches require a large amount of 
input RNAs [81,82]. Recently, microarray and bead based assays are used for high-
throughput miRNA profiling for fast screening and comparative expression analysis of 
miRNAs in biological samples, but have a limited sensitivity and specificity due to the 
potential non-specific annealing inherent for hybridization-based methods [84-87]. 
Recent applications of deep sequence technology have greatly facilitated and simplified 
the analysis of miRNAs and made the investigation of small RNA repertoires of cells 
possible at the unprecedented resolution of hundreds of millions of reads [80, 81]. 
However the cost-intensive equipment and reagents and the complicated data process and 
bioinformatics analysis of deep RNA sequencing may not practical or affordable for 
routine miRNA analysis in majority of research laboratories. RT-PCR is a gold standard 
for gene expression analysis [88] and exhibits a high degree of sensitivity and specificity 
[89]. Chen et al. developed a TaqMan based stem-loop RT-PCR for a real-time 
quantification of miRNAs and demonstrated a high sensitivity and specificity [90]. This 
method, however, was designed to quantify a given miRNA with only one stem-loop RT 
primer based on the predicted mature miRNA sequence but cannot verify and detect 
processed mature miRNA species with variations or modifications at their 3’ and 5’ ends. 
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Furthermore, the recent studies have revealed amazing complexity in the miRNA-
mediated regulatory mechanisms and biological functions, which involves multiple steps 
of miRNA processing, target recognition, binding, and cleavage, and interactions with 
other miRNAs, protein cofactors, and signaling pathways [72, 74-76]. To determine the 
precise mechanism of action and better understand the regulatory function of endogenous 
miRNAs in a complex biological system such as in mammalian cells,  advanced 
molecular biological and biochemical tools and methods are much needed to efficiently 
and accurately identify and quantitatively measure intermediates and end-products 
resulted from the miRNA action in multicellular organisms under physiological 
conditions.   
    For these purposes, we developed a novel stem-loop array reverse transcription 
polymerase chain reaction (SLA-RT-PCR) approach to systematically verify and detect 
the endogenous miRNAs and the target mRNA and DNA cleavage fragments by 
accurately identifying their unique nucleotide ends generated during miRNA processing 
and molecular action of siRNA and restriction enzymes (REs) in human cells. We used 
the endogenous miRNA, the synthetic siRNA with an ectopically expressed mRNA target 
template, and the REs with DNA templates as testing models to evaluate sensitivity, 
specificity, and efficiency of the SLA-RT-PCR assay. Our results demonstrated the great 
potential and broad applications of using the SLA-RT-PCR as a sensitive, cost-efficient, 
and high-throughput tool to systematically determine the biogenesis and expression of 
endogenous miRNAs and their mechanisms of action in multicellular organisms under 
physiological conditions.   
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3.2 Methods and Materials  
3.2.1 SLA-Reverse-transcription 
    Reverse transcriptase reaction (RT) contains total RNA samples prepared from human 
lung and cervix cancer cell lines and normal HBE cells. The RNA sample was briefly 
treated with (0.04U/ µl as final concentration) RNAase-free DNAase I. RNA was 
reversed transcribed using the High Capacity Reverse Transcription kit (Life 
Technologies, Applied Biosystems) in combination with an array of stem-loop RT-
primers. The 20 µl of RT reaction contains 50 ng of total RNA, 5×10-12 mol of SLA-RT 
primer, 2 µl 10x RT buffer (Applied Biosystems), 1 µl Multiscribe reverse transcriptase 
(Applied Biosystems), and 0.8 µl 100 mM of dNTP mix (Applied Biosystems). To 
increase reverse transcription efficiency, a pulsed RT reaction was performed on a 
DNAEngine Peltier Thermal Cycler (BIO-RAD) with 60 cycles at 18 °C for 1 min and 37 
°C for 1 second, followed by 60 cycles at 20 °C for 1 min, 37 °C for 1 second, 37 °C for 
30min, 42 °C for 20 min, 85 °C for 10 min, and then held at 4 °C.   
3.2.2 SLA-PCR 
    For regular PCR, each cDNA sample generated from the SLA-RT reactions was 
diluted 500 fold. The 20 µl of PCR reaction contains 1µl diluted RT product, 2 µl 
10×standard PCR buffer, 0.8 µl 10mM dNTP, 0.5 µl 100mM MgSO4, 0.2 µl Taq 
polymerase, 1µl 10nm of forward primer and 1µl 10nm of reverse primer.  PCR reactions 
were conducted as at 95 °C for 5 min followed by 35 cycles at 95 °C for 15 s, 61 °C for 
30s, and 37 °C for 30s, and 72 °C 10 min, on DNAEngine Peltier Thermal Cycler (BIO-
RAD).  
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3.2.3 miRNA detection real-time PCR 
    For real-time RT-PCR, a Taqman® Real-time RT-PCR for miRNA detection kit was 
used (Applied Biosystems). The 15 µl of RT reaction consisted of 7 µl master mix, 3 µl 
5×RT stem-loop RT primer, and 5 µl RNA sample (20 ng). The 7 µl of master mix 
contained 1.5 µl 10× RT buffer, 0.15 µl 100 mM dNTPs, 1µl 50 U/µl MultiScribe reverse 
transcriptase, and 0.19 µl 20 U/µl RNase inhibitor. RT reactions were incubated for 30 
min at 16°C, 30 min at 42°C, 5 min at 85°C, and then held at 4°C.  The 20 µl of real-time 
PCR included 1.33 µl RT product, 10 µl 2× TaqMan® Universal PCR Master Mix, 1 µl 
TaqMan® small RNA assay, and 7.67 µl H2O. The reactions were incubated at 95°C for 
10 min, followed by 40 cycles at 95°C for 15 s and 60°C for 1 min. The threshold cycle 
(CT) is defined as the cycle number at which the FAM fluorescence signal passes the 
fixed threshold, and were converted into relative miRNA expression by using U6 small 
RNA as endogenous control. 
3.2.4 SLA-RT-PCR product detection by agarose gel electrophoresis 
    PCR products resulting from SLA-RT-PCR were analyzed by agarose gel 
electrophoresis in 1x Tris-borate-EDTA (TBE) buffer containing 89 mM Tris Base, 89 
mM Boric Acid, and 2 mM EDTA, pH 8.0. TBE buffer was useful for separation of 
smaller DNA fragments because it has a greater buffering capacity and gives a sharper 
resolution than that of TAE buffer. 
3.2.5 Fluorescence-based DNA fragment size analysis  
    In many of our SLA-RT-PCR products the sizes of non-specific primer dimmers are 
similar to PCR products and it is difficult to distinguish them by size from agarose gel. 
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Therefore, a fluorescence-based DNA fragment size analysis (FBFSA) [41] was 
performed to accurately determine differences between non-specific and specific PCR 
products. Fluorescently labeled fragments were detected using the Applied Biosystems 
3730 Genetic Analyzer and the size of each PCR fragment was determined using 
Genotyper analysis software by comparing it with the standard curve for that specific 
fragment lane.  Accuracy of less than one base difference could be seen between sample 
replicates. Higher throughput can be achieved by multiplexing different dyes and 
fragment sizes together.  
 
3.3 Results  
3.3.1 SLA-RT-PCR  
     We developed a novel SLA-RT-PCR technique to systematically verify and detect the 
endogenous mature miRNAs and the intermediate mRNA fragments cleaved by siRNA 
by accurately identifying their unique nucleotide ends generated during miRNA 
processing and by siRNA-mediated target cleavage in human cells. The SLA-RT-PCR 
assay includes two steps: SLA-RT and PCR. The principle of works, experimental 
design, and assay procedures are illustrated in Figure 12. The stem-loop-array RT-
primers comprise two unique sequence components: a short single-stranded stretch (6 
bases) at the 3’ end of the primer oligonucleotide that is miRNA-specific and hybridizes 
to the end of mature miRNA and a double stranded stem at the 5’ end that forms stem-
loop to function as a forceps to stabilize the secondary structure of the primer. The 
specific sequences of the mature miRNA is recognized by the six-nucleotide 
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complementary extension at the 3’ends of the RT-primer array, which can efficiently 
reverse transcribe the miRNA into cDNA (Figure 12, Step 1). The use of an array of 
stem-loop RT primers allows to accurately recognizing and verifying unique ends of the 
RNA or DNA fragments processed by endonucleases. If the SLA-RT primers have no 
perfect match, on both the length and the base, to the sequence of the 3’ or 5’ end of a 
RNA fragment the efficiency of RT reaction will be dramatically reduced. The size and 
relative amount of SLA-RT-PCR products can be detected by agarose gel electrophoresis 
or a quantitative real-time RT-PCR.  For subsequent PCR (Figure 12, Step 2) it is 
proceeded with a pair of forward and reverse primers that contain antisense sequence 
complementary to the 5’-end of miRNA and to the 3’-end of the stem loop of RT- primer, 
respectively.  
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Figure 12. Schema of SLA-RT-PCR assays for miRNA detection and verification. The 
SLA-RT PCR assay includes two steps: SLA-RT and PCR. The stem-loop-array (SLA) 
RT-primers bind to the ends of mature miRNAs. Specific sequences of mature miRNA 
species are recognized by the six-nucleotide (nt) complementary extension at the 3’- or 
5’-ends of SLA-RT primers, which can reverse transcribe the miRNA into cDNA with 
varied efficiency (Step 1). The highest RT efficiency and specificity will be detected in 
RT reactions with SLA-RT primers containing 6-nt stem sequences perfectly matched to 
those at ends of the mature miRNA will exhibit and a dramatically reduced efficiency 
(10-100 fold less) and specificity will be noticed in RT reactions with SLA-RT primers 
having no perfect matches or mutations. The subsequent PCR (Step 2) is preceded with a 
pair of forward and reverse primers that contain antisense sequence complementary to the 
3’ or 5’ end of miRNA and to the 5’ or 3’-end of SLA-RT primer, respectively. 
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3.3.2 Verification of 3’ ends of synthetic RNU44 RNA and DNA fragments by SLA-
RT-PCR 
     We first used synthetic small RUN44 RNA or DNA templates as model systems to 
evaluate the SLA-RT-PCR for detection and verification of the 3’ end of RUN44 RNA 
and DNA fragments. RNU44 is a member of abundant intronic small-nucleolar RNAs 
that were frequently used as reference genes for measuring endogenous miRNA 
expression [75]. It has a predicted RNA sequence of 66 nucleotides (Figure 13). We 
designed 12 SLA-RT-primers that are different by one nucleotide from each other 
(Figure 13) and performed SLA-RT-PCR reactions using synthetic RNU44 RNA and 
DNA as templates and analyzed SLA-RT-PCR and SLA-PCR products, respectively, by 
agarose gel electrophoresis (Figure 14).  
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Figure 13. Detection and verification of 3’ and 5’ ends of synthetic and endogenous 
small nucleolar RNU44 RNAs by SLA-RT-PCR. A, The predicted full length RNU44 
RNA sequences with 5’ and 3’ end sequences (underlined) targeted by SLA-RT-5’-
primers and SLA-RT-3’- primers, respectively. 
       
     As expected, the SLA-RT primers ending in AGTCAG (primer 1), GTCAGT (primer 
5), TCAGTT (primer 6), TGTCAG (primer 9), and AGTCAGT (primer 10) that process 
perfect or near perfect match to the 3’end sequences of RUN44  successfully reverse-
transcribed RNU44 RNA with a high efficiency. However, the RT primers with 
mutations at 3’ end or in the middle of RT-primer sequences, including AGTCAC 
(primer 2), AGTCTC (primer 3), AGTGTC (primer 4), TCACAG (primer 7), AGTGTG 
(primer 11) and AGAGTG (primer 12), could not reverse-transcribe RNU44 or showed 
dramatically reduced efficiency (Figure 14, panel I). Similar results were also 
demonstrated in PCR reactions with same primer sets using RNU44 DNA as a template 
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with either the same nucleic acid sequences corresponding to RNA sequences (Figure 14, 
panel II) or with one base (T) added at the 3’-end (Figure 14, panel III). The predicted 
sizes and sequences of the SLA-RT-PCR products with primers 1 (AGTCAG), 5 
(GTCAGT), 6 (TCAGTT), 9 (TGTCAG), and 10 (AGTCAGT) (primer 10) were further 
confirmed by fluorescence-based fragment size analysis (FBFSA) (Figure 16, Array I) 
and DNA sequencing (Figure 16), respectively. These results indicate the high specificity 
of the designed SLA-RT primers to the 3’ end sequences of RNA or DNA fragments.  
 
 
Figure 14. Detection and verification of 3’ ends of synthetic RNU44 RNA (I, 44nt) and 
(II, 45 nt) and DNA (III, 61 bp) and (IV, 62 bp) templates by SLA-RT-3’-primers (Fig 
13) on agarose gels. Sequences of synthetic RNU44 RNA and DNA templates are 
described at the bottom of gel graphs and the predicted specific SLA-RT-PCR products 
are indicated by arrows on the left sides of gels. 
    
3.3.3 Detection and verification of 3’ and 5’ ends of endogenous RNU44 RNAs in 
H1299 Cells 
     We used two sets of SLA-RT-primers to detect and verify the 3’ and 5’ ends of 
endogenous RNU44 RNAs in H1299 cells (Figure 15). The same set of 3’ SLA-RT 
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primers as shown in Figure 13 (SLA-RT 3’-primers) was used to detect the 3’ end of 
RUN44 RNA in H1299 cells (Figure 15, panel I). Similarly, the RT products of RNU44 
were detected with a high efficiency in RT reactions containing primers 1, 5, 6, 9, and 10 
but were not detectable in RT reactions with mutation-bearing primers 2, 3, 7, 11, and 12 
or detected in dramatically reduced efficiency with primers 4 and 8, respectively (Figure 
15). The sizes and sequences of these 3’-SLA-RT products amplified from endogenous 
RNU44 RNAs were further confirmed and verified by both FBFSA and DNA sequencing 
(data not shown). These results indicate that a large population of RNU44 RNAs 
expressed in H1299 cells is ended with sequences of ACUGAC at their 3’ ends but 
without the predicted U (Figure 13) at their termini. 
 
Figure 15. Detection of 3’ and 5’ ends of endogenous RNU44 RNAs in H1299 cells by 
SLA-RT-PCR on agarose gels, using two sets of SLA-RT primers shown in Figure 13 
and run in TBE buffer. The predicted specific SLA-RT-PCR fragments are indicated by 
arrows on the left sides of gels.  
 
    We also used a set of 5’-SLA-RT primers to detect and verify the 5’ ends of 
endogenous RNU44 RNAs in H1299 cells (Figure 15, panel II).  The 5’-RT-PCR 
products amplified from endogenous RNU44 RNAs were detected with a high efficiency 
in RT reactions containing 5’-SLA-RT primers 13 (CCTGGA), 19 (CTGGAT), and 20 
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(TGGATG) with perfectly matched complementary sequences to the 5’ ends of RNU44, 
but were not detectable in RT reactions containing RT primers 14 to 18 and 21 to 24 with 
mutations at 3’ end or in the middle of the RT primer (Figure 15).  The 5’-SL-RT primer 
#19 ending in CTGGAT reversely transcribed RNU44 with the highest efficiency 
(Figure 15, panel II). The sizes and sequences of these 5’-SLA-RT products amplified 
from endogenous RNU44 RNAs were further confirmed and verified by both FBFSA 
(Figure 16, FDFSA profiles/5’-SLA-RT-PCR) and DNA sequencing.  These results 
suggest that a large population of RNU44 RNAs in H1299 cells is ended with sequences 
of CUGGAU at their 5’ ends but without the predicted nucleotide “C” (Figure 13) at 
their 5’-termini.  Together, these results indicate the high specificity and efficiency of 
SLA-RT-PCR in detection of both 3’ and 5’ ends of endogenously expressed or 
processed RNA fragments. 
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A                                                                      B 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 16. Verification of SLA-RT-PCR products. (A) Verification of sizes of SLA-RT-
PCR products by fluorescence-based fragment size analysis (FBFSA). Representative 
FBFSA profiles corresponding to individual 3’ SLA-RT primers (left panels) and 5’ 
SLA-RT primers (right panels). The verified sizes of specific SLA-RT-PCR DNA 
fragments are indicated by arrows. (B) Confirmation of identities of specific SLA-RT-
PCR fragments by DNA sequencing. Representative DNA sequencing histograms are 
shown in SLA-RT-PCR reactions with synthetic RNU44 RNA templates and 
corresponding SLA-RT primers as indicated on the top. 
 
 
 
3.3.4 The dynamic range and sensitivity of SLA-RT-PCR 
    To evaluate the dynamic range and sensitivity of the SLA-RT-PCR assay, we used two 
synthetic small RUN44 RNAs as templates. The RNU44 RNA template I (Figure 17) 
contains the predicted full 66-base sequences ending with “U” at the 3’ terminal and the 
template II (Figure 17) contains the verified RNU44 RNA sequences without “U” at the 
3’ end.  SLA-RT primer was used to specifically detect the 3’-end of RNU44 RNA 
templates I and II. Synthetic RUN44 RNAs were quantified based on the A260 reading 
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and made a series of dilution over a range of eleven orders of magnitude from 10-18 to 10-
28 mole (Figure 17). SLA-RT primer could successfully reverse-transcribe the RNU44 
RNA template A (Figure 17). However, as expected, a reduced RT efficiency was 
observed in SLA-RT-PCR reactions because of the one-base over the reach by this stem-
loop primer at the 3’end of RNU44 RNA template II (Figure 17). These results further 
demonstrated the specificity of SLA-RT-PCR assay.  
 
 
 
Figure 17. Dynamic range and sensitivity of the SLA-RT-PCR assay. The SLA-RT-PCR 
reactions were performed using SLA-RT primers and known concentrations of input 
synthetic RNU44 RNA templates I and II over ten orders of magnitude from 10-18 to 10-28 
mole. The specific SLA-RT-PCR products were analyzed by agarose gel electrophoresis 
(upper panels) and corresponding liner regression plots of the log RNA template input 
(mole) vise the relative output of SLA-RT-PCR products are presented in lower two 
panels. 
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     The SLA-RT-PCR assay showed an excellent linear output of RT-PCR products 
corresponding to the input of RNA templates over a dynamic detection range at lease of 
five orders of magnitudes (from 10-18 to 10-22 mole) and demonstrated an extremely high 
sensitivity that is capable of detecting as few as 10-22 mole in PCR reactions with both 
RNU44 RNA templates and specific SLA-RT primers on agarose gel (Figure 17).   
 
3.3.5 Detection and verification of 3’-end of mammalian miR-98 in mammalian cells 
    We used a human hsa-miR-98 as a model miRNA molecule to evaluate the SLA-RT-
PCR assay for detecting and verifying the 3’-ends of endogenous miRNAs in human cells 
(Figure 18). The hsa-miR-98 is a member of let-7 miRNA family and its structure and 
function have been extensively investigated in multi-organisms. The predicted secondary 
structure and mature sequences of pri-miR-98 from miRBase data base 
(http://www.mirbase.org) [94] is shown in Figure 18A. We designed 9 SLA-RT-primers, 
which are complementary to the 3’ end of miR-98 (Figure 18B).  
 
Figure 18. Detection and verification of mature miR-98 species in human cells by SLA-
RT-PCR. (A) Predicted secondary structure of has-miR-98. The mature miR-98 
sequences are presented in red. (B) SLA-RT 3’-primers for detection of 3’-ends of mature 
miR-98 and corresponding sequences of cDNA fragments by RT reactions. 
A 
B 
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    The endogenously expressed and processed mature miR-98 RNAs showed predicted 
sequence reads at their 3’ ends with varied levels of distribution in H1299 cells, as 
demonstrated by specific SLA-RT-PCR fragments in RT-PCR reactions containing SLA-
RT primers 6, 7, 8, and 9 and by an increased level of distribution of mature miR-98 
species detected in reactions containing SLA-RT primers 6 to 9 (Figure 19). Similar 
results to those shown in Figure 19 were also obtained in exogenously expressed and 
endogenously processed mature miR-98 RNAs in H1299 cells, using the same set of 
SLA-RT primers (Figure 19).  These results demonstrate the reliability and accuracy of 
the SLA-RT-PCR in detection and verification of end reads and levels of processed 
mature miRNA species in mammalian cells.   
 
 
Figure 19. SLA-RT-PCR detection of miR-98 in H1299 cell. PCR corresponding to 
individual  SLA-RT primers was shown in Figure 18. The predicted size of specific SLA-
RT-PCR is indicated by arrow on the left side. MK, molecular marker, NC, negative 
control. SLA-RT-PCR reactions without SLA-RT primer was used as a control.  
 
46 
 
 
Figure 20. SLA-RT-PCR detection of miR-98 in Hela cells with (+) or without (-) 
exogenous transfection of miR-98 gene expressing plasmid. PCR corresponding to 
individual  SLA-RT primers was shown in Figure 18.  The predicted size of specific 
SLA-RT-PCR is indicated by arrow on the left side. 
 
      Based on these SLA-RT-PCR results of the distribution of mature miR-98 RNAs in 
H1299 cells, we compared the distribution and expression levels of endogenous miR-98 
RNAs among normal bronchial epithelial HBE, NSCLC H1299, and cervix cancer Hela 
cells with or without the ectopic expression of miR-98, using above tested SLA-RT 
primers 6-9 (Figure 21A). Different levels of expression and distributions of mature 
miR-98 species were observed in different cells and cell lineages (Figure 21A).  
Particularly, the mature miR-98 species with 3’-end in “CAACAA” detected by RT 
primer #6 showed lowest distribution across all these cell lines and a highest level of 
miR-98 expression could be detected in RT-PCR reaction using RT primer #9 in H1299 
cells, whereas the highest level of mature miRNA species were detected using primer #8 
in HBE and Hela cells (Figure 21A). For comparison, we also performed a quantitative 
real-time SL-RT-PCR to determine the expression of miR-98 in these cells using an 
Applied Biosystems SL-qRT-PCR miRNA detection kit, which contains one SL-RT 
primer with similar sequences to those of our SLA-RT primer #6 (Figure 21B).   The 
quantitative real-time SL-RT-PCR results exhibited a similar trends and magnitudes of 
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miR-98 expression in these cells to those detected by SLA-RT-PCR using RT primer #6 
(Figure 21B and C).  
 
 
 
 
Figure 21. The distribution and expression levels of endogenous miR-98 RNAs among 
normal HBE, H1299, and Hela cells. (A) A highest level of miR-98 expression could be 
detected in using RT primer #9 in H1299 cells, whereas the highest level of mature 
miRNA species were detected using primer #8 in HBE and Hela cells. (B) Relative 
distribution of mature miR-98 species detected by SLA-RT primers #6, 7, 8, and 9, 
respectively, in human HBE, H1299 and Hela cells. (C) Detection and quantification of 
endogenous miR-98 by a quantitative real-time SL-RT-PCR miRNA detection assay 
(Applied Biosystem). 
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     These results further confirmed by FBFSA and DNA sequencing (data not shown) and 
clearly demonstrated the accuracy and advantage of SLA-RT-PCR assay in verification 
and detection of different mature miRNA species in different cell lines or organisms over 
the current SL-RT-PCR assay with a fixed SL-RT primer for a given miRNA.  
 
 
Figure 22. Effects of RT temperature on the specificity and efficiency of SLA-RT-PCR 
reactions in detection of mature miR-98 species in HBE, Hela and H1299 cells. PCR 
corresponding to individual  SLA-RT primers was shown in Figure 18. SLA-RT reaction 
was performed at 20 C (A), 18 C (B) and 14 C (C). 
 
      Furthermore, we evaluate the effects of RT temperature on the specificity and 
efficiency of SLA-RT-PCR reactions in detection of mature miR-98 species in human 
normal bronchial epithelia and tumor cells (Figure 22). We generally performed a SLA-
RT reaction at 20 C as a standard RT temperature. An increased amplification of both 
the specific and the non-specific RT-PCR products was observed when RT temperature 
was lowered from 20 C to 18 C or 14 C. The patterns of SLA-RT-PCR corresponding 
to individual SLA-RT primers, however, remained unchanged in reactions with varied 
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RT temperatures. These results further confirmed the specificity and reproducibility of 
the SLA-RT-PCR assay. 
 
3.3.6 Verification and detection of the site-specific DNA cleavage by restriction 
endonucleases 
    Restriction endonucleases (REs) are endonuclease that can cleave double-stranded (ds) 
DNAs at specific sites and generate cleaved DNA fragments with unique 3’ and 5’ 
overhangs with defined length and bases. We used the well-defined restriction cleavage 
sites and patterns on DNA templates as model systems to evaluate the potential of using 
SLA-PCR assay to determine and verify the actual cleavage sites and the cleaved DNA 
fragments by endonuclease RE activities. The RE Kpn I recognizes the palindromic 
double-stranded DNA sequence 5’-GGTACC-3’ and cleaves DNA by generating a 4-
base 3’-overhang; and the Acc651 is an isoschizomer of Kpn I, recognizes the same DNA 
sequence but produces DNA fragments that have a strictly 4-base 5’-overhang (Figure 
23A). We used a SLA-PCR strategy, which applies the same principle of works as the 
SLA-RT-PCR, to precisely map the actual cleavage sites by Kpn I and Acc651 by 
detecting and verifying the 3’- and 5’ overhangs of the intermediates and final products 
of RE reactions on DNA templates (Figure 23B and C). The Acc651 exhibited a 
stringent RE cleavage pattern that generates RE DNA fragments predominantly with 5’-
AGCTCG overhangs, as amplified by the specific SLA-primer ending in “CGAGCT” 
(Figure 23B, primer 10 and Figure 23C).  In contrast, the Kpn I showed a promiscuous 
RE activity, generating a mixture of RE DNA fragments with random cleavage sites 
(Figure 22B and C). These results clearly demonstrate the sensitivity and specificity of 
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SLA-PCR in detecting and verifying the intermediates and products of endonuclease 
activities.  
 
 
 
Figure 23. Detection of the site-specific DNA cleavage by restriction endonucleases 
KpnI and ACC65I. (A) The restriction endonuclease map by KpnI and ACC65I. (B) SLA 
-PCR strategy to detect the actual cleavage sites by KpnI and ACC65I. (C) SLA -PCR  
precisely map the actual cleavage sites by Kpn I and Acc651 by detecting and verifying 
the 3’- and 5’ overhangs of the intermediates and final products of RE reactions on DNA 
templates 
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3.3.7 Detection and verification of siRNA-mediated mRNA cleavage site by SLA-
RT-PCR 
        To further evaluate the potential application of SLA-RT-PCR assay in identifying 
novel miRNA targets and molecular mechanisms of action, we used the siRNA-mediated 
target mRNA cleavage as a model system to precisely detect and verify the intermediates 
and end products of the siRNA activity in mammalian cells under physiological 
conditions. It has been shown that mammalian siRNAs (21 and 22 nt) silence gene 
expression by cleaving their target mRNAs for the sequential degradation and the siRNA 
cleavage site on the mRNA target is usually located in the middle of the region spanned 
by the siRNA duplex, following a canonical pattern of 10 bp from the 5′-end of siRNA in 
the RNA-induced silencing complex (RISC) [95]. The RISC-associated argonaute 2 (Ago 
2) protein cleaves the target mRNA into two distinct fragments: a 5′ fragment with a 3′ 
hydroxyl group, and a 3′ fragment with a 5′ phosphate. The 5’ fragment can be amplified 
using SLA-RT-PCR with 3’-SLA-RT primers. We used a Dharmacon siRNA transfection 
reagent (Dharmacon, Chicago, IL) to deliver a synthetic siRNA that was derived from 
mature hsa-miR-98 and transfected a plasmid vector expressing hsa-miR-98 gene as the 
siRNA target template into H1299 cells to determine the siRNA cleavage products by 
SLA-RT-PCR (Figure 24). The miR-98-siRNA-mediated cleavage site on the miR-98 
mRNA target was precisely detected by the SLA-RT-PCR in the middle of mature miR-
98 region at the predicted position “G”, which is 10 bp from the 5′-end of siRNA duplex, 
as shown in Figure 24A and indicated by arrow. The identity of the SLA-RT-PCR 
products was further verified by DNA sequencing (Figure 24B and 24C).  
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Figure 24. Detection of siRNA cleavage site by SLA-RT-PCR assay. (A) The predicted 
size of SLA-RT-PCR fragment amplified by SLA-RT primer #16. (B) sequences of 
siRNA and its target and SLA-RT primers. The sequences of the SLA-RT primer (#16) 
anticipated for efficiently detecting the predicted siRNA cleavage site on target RNA 
template is underlined. (C) Detection of siRNA cleavage site in H1299 cells co-
transfected with siRNA and target RNA expressing plasmids by SLA-RT-PCR. (D) DNA 
C 
D 
A 
B 
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sequencing confirmation of the siRNA cleavage site and the cleaved RNA fragment 
detected by SAL-RT-PCR. 
 
    These result clearly demonstrated the potential applications of SLA-RT-PCR in 
identifying authentic miRNA targets and determine their mechanisms of action by 
precisely detecting and verifying the cleavage sites on target mRNAs mediated by 
miRNAs in the Ago 2-mRISC in mammalian cells under physiological conditions. 
 
3.4  Discussion 
   Since the initial discovery, more than 1000 miRNAs have been experimentally 
identified or predicted by computational methods in human genome 
(http://www.mirbase.org) [94]. Different sets of miRNAs have been found to be 
expressed in different organisms, tissue and cell types [76,82,96] and they may target 
about 60% of mammalian genes [74, 97]. Consequently, great efforts have currently been 
attributed to identify miRNA biomarkers and signatures associated with various human 
diseases including cancer and to explore their biological roles and therapeutic potentials 
[77, 98, 99]. These studies will greatly benefit from accurate identification and 
quantification of endogenous miRNAs and determination of precise mechanisms of their 
action.   
   The mature miRNA molecules have been shown to be varied in length and base 
compositions or have modifications at their ends [100]. Accurate determination, 
verification and quantification of miRNAs in a complex biological system are technically 
challenging but essential for a better understanding of biological roles of miRNAs in 
regulation of gene expression and disease pathogenesis. The currently used approaches 
for miRNA profiling, detection, and quantification rely on the miRNA sequence data 
54 
 
presented in various miRNA databases such as miRBase, which are neither accurate nor 
complete in representing variations and modifications of endogenous miRNAs in a 
specific organism and cell type.  The small size and the complexity of mature miRNA 
reads present a unique challenge for the conventional RT-PCR-based miRNA detection 
and quantification methods. Chen and colleagues developed a TaqMan based stem-loop 
RT-PCR for a real-time quantification of miRNAs and demonstrated a high sensitivity 
and specificity [90].  This method was, however, designed to quantify a given miRNA 
with only one pair of primers based on the predicted mature miRNA sequence but it 
cannot verify and detect processed mature miRNA species with the unique and specific 
3’ end and 5’ ends directly processed from their pre-miRNA sequences and overlooked 
the critical distribution patterns of processed miRNA repertoires in a given biological 
system. As demonstrated in this study, mature miR-98 species showed different 
distribution and levels in different cell types and lineages and the different miRNA 
molecules with different processed ends could clearly be identified and detected by SLA-
RT-PCR assay with miRNA end-sequence specific SLA-RT primers. The miR-98 
molecules with 3’-end in “CAACAA” showed a lowest distribution while miR-98 
molecules with 3’-end in “CAATAC” exhibited highest level in H1299 cells. In contrast, 
a very low level of miR-98 expression was detected by a commercially available 
quantitative real-time SL-RT-PCR because its fixed SL-RT primer can only detect the 
miR-98 species that showed the lowest distribution in H1299 cells, as detected by one of 
SLA-RT primers. Such results from conventional SL-RT-PCR can be misleading in data 
interpretation regarding to the miRNA expression status. Our results clearly demonstrated 
the accuracy and advantage of SLA-RT-PCR assay in verification and detection of 
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different mature miRNA species in different cell lines or organisms over the current SL-
RT-PCR assay with a fixed SL-RT primer for a given miRNA, which overlooks the 
importance of the significantly-varied distribution of mature miRNA species in different 
cell types or organisms. The SLA-RT-PCR assay also showed an excellent linear output 
of RT-PCR products corresponding to the input of RNA templates over a dynamic 
detection range at lease of four orders of magnitudes (from 10-15 to 10-18 mole) and 
demonstrated an extremely high sensitivity that is capable of detecting as few as 10-21 
mole in PCR reactions. 
    We used an agarose gel electrophoresis and gel staining with ethidium bromide to 
separate and detect the SLA-RT-PCR products. However, it is very difficult to use this 
method to distinguish non-specific bands from specific RT-PCR products when their 
sizes are small and similar. Thus, we used a fluorescent-based fragment size analysis 
(FBFSA) to more accurately measure the size of PCR products. The FBFSA 
demonstrated that the SLA-RT-PCR could successfully verify sizes of SLA-RT-PCR 
products by precisely detecting 3’ and 5’-ends of mature miRNAs based on pre-miRNA 
sequences. Many current studies addressing the role of miRNAs in various human 
diseases including cancer have emphasized the need for accurately determining the 
sequences of large numbers of miRNAs [97, 100]. However, it has been a persisted 
challenge to verify sequences of small miRNAs with an averaging ~ 22 nt in length. Our 
study convincingly demonstrated the potential of using SLA-RT-PCR method as a 
sensitive and efficient biochemical and molecular tool to verify end sequences and 
authentic species of endogenous miRNAs in mammalian cells.  
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     Endonucleases such as restriction enzymes (REs) are widely-used molecular biology 
tools. We used the SLA-PCR assay to detect and verify RE activities of two RE 
isoschizomers, Kpn I and Acc651, under stringent and relaxed restriction reaction 
conditions. The SLA-PCR results provided first-handed molecular evidence confirming 
those previous findings shown that the Kpn I could introduce unpredicted cuts in the 
plasmid vector and the DNA insert and that the Acc65I offered more stringent restriction 
cutting patters than the Kpn I and are more desirable for conditional cloning [103]. Our 
results clearly demonstrate the sensitivity and specificity of SLA-PCR in detecting and 
verifying the intermediates and products of endonuclease activities. 
    The cleavage and process of dsRNAs, such as siRNA, pre-miRNAs, and siRNA- or 
miRNA-target mRNA duplexes, have been shown to be mediated by an intrinsic 
endonuclease activity of argonauta (Ago) enzymes [94-109].  However, no confirmative 
evidence has been commonly reported to demonstrate the actual mRNA cleavage events 
mediated by siRNA-Ago2 activities in the RISC.  Such efforts might partly been hindered 
by technic difficulties in detecting and verifying the cleavage sites and the cleaved 
mRNA intermediates and end products.  The therapeutic applications of using siRNAs to 
silence the pathogenic genes in clinical practice have also been hampered by their off-
target effects and difficulties in confirming that the observed mRNA knockdown is the 
direct result of an RNAi-mediated event [110].  RACE (rapid amplification of cDNA 
ends)-PCR and molecular cloning are commonly used to study the siRNA-Ago2 
mediated target mRNA cleavage activities but these methods are very time-consuming 
and labor-intensive [111]. The new SLA-RT-PCR technique presented in this study takes 
advantages of the high fidelity of SLA-RT primers in recognizing the specific ends of 
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DNA and RNA fragments generated by REs and siRNA-Ago2 activities, respectively, 
and the sensitivity of PCR to efficiently and precisely detect target mRNA cleavage sites 
by siRNAs, suggesting that the SLA-RT-PCR could be used to confirm that the siRNA-
mediated mRNA cleavage mechanisms.  
    In summary, we have developed a novel SLA-RT-PCR assay to efficiently and 
accurately detect the distribution and relative quantity of the endogenously or 
exogenously expressed  miRNAs in mammalian cells by determining the authentic 3’end 
and 5’ ends of mature miRNAs processed from their pre-miRNA sequences. We also 
used the SLA-RT-PCR to accurately detect the specific sites and intermediate nucleic 
acid fragments of DNA and mRNA targets cleaved by the restriction endonucleases in 
solution and by the siRNA-Ago2 activity in the RISC in human cells, respectively.  Our 
results demonstrated the great potential and broad applications of using the SLA-RT-PCR 
as a sensitive, cost-efficient, and high-throughput tool to systematically determine the 
biogenesis and expression of endogenous miRNAs and to identify authentic miRNA 
targets and determine mechanisms of siRNA and miRNA action by precisely detecting 
and verifying the cleavage sites on target mRNAs mediated by siRNA or miRNAs in the 
Ago2-RISCs in mammalian cells under physiological conditions. 
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Chapter 4. Target mRNA cleavage and degradation mediated by endogenous 
mammalian miRNAs  
4.1 Introduction 
   Small RNA Lin-4 was first reported miRNA as gene regulatory molecule in 1993 [112] 
and miRNA was later identified as a large class of short, single stranded RNAs presented 
naturally in most eukaryotic cells [113,114,115]. Mature miRNAs are incorporated into 
argonaute proteins as guide sequence in the assembling of miRNA-induced silencing 
complex (miRISC) for target-specific gene silencing [116]. Plant miRNAs match their 
mRNA target complementarily to ensure irreversible cleavage of target mRNAs and this 
is thought to be the predominant mode of miRNA mechanism in plants [117]. In 
mammalian cells, extended miRNA: target pairing are rare and miRNA recognizes 
mRNA targets with much shorter base pairs usually located at highly conserved 
nucleotides (nt) at position 2 -7 of miRNA 5’ termini with compensatory support from 3’ 
supplementary pairing [118]. The algorithm of mammalian miRNA: target recognition 
makes it possible that a single miRNA might target hundreds of potential mRNA 
transcripts genome-wide. Over the past few years, remarkable progress has been made in 
our understanding of miRNA biogenesis and function; however, the mechanism that 
miRNA use to regulate gene expression remains unclear. Earlier studies suggest that the 
miRNA-induced gene expression interference is through binding to the 3’UTR of target 
mRNA and repressing translation. Recent studies suggest that the mammalian miRNAs 
predominantly act to decrease target mRNA levels. However, no direct evidence for 
miRNA-mediated target mRNA cleavage and degradation has been demonstrated in 
mammalian cells [119-121].  
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    Previous studies indicated that miRNA participate in the regulation of many crucial 
cellular process. It was also predicted that mammalian miRNAs can regulate ~30% of all 
protein coding genes by bioinformatics groups. The mechanism for miRNAs in 
repressing protein synthesis is still poorly understood. miRNAs can affect both the 
translation and stability of mRNAs, but the results from different studies have often been 
contradictory. The recent development of ribosome profiling has provided a sensitive 
method to verify that regulation by miRNA is mainly through mRNA destabilization.       
    In plants, miRNA pair to mRNAs with nearly perfect complementarity and trigger 
endonucleolytic mRNA cleavage. In mammalians, there are rare examples of near-perfect 
complementarity between miRNA and target site that enables cleavage of the mRNA, 
such as in the case of miR-196 and HoxB8 mRNA [124].  Most cases, however, involve 
duplexes that contain mismatches and multiple nucleotide bulges. Therefore, it is difficult 
to predict and validate the target cleavage sites. In human somatic cells, argonaute protein 
superfamily is composed of endonucleolytic-capable Ago2 protein and non-catalytic 
Ago1, Ago3 and Ago4 proteins [122]. Ago2 is the only Ago that functions in the RNAi 
because the RNase H-like-P-element induced PIWI domain, but not other Agos, can 
cleave mRNA at the center of the siRNA-mRNA duplex. Ago2 is the only AGO that 
partially because of the difference of catalytic capability of Ago2 and the noncatalytic 
nature of other argonaute proteins, translational suppression and mRNA degradation were 
both proposed as possible mechanisms in mammalian cells [123]. 
    Later, a limited number of mRNA cleavages were mapped to near perfectly matched 
miRNA:target with deep sequencing approaches. Owing to the limited cases of cleavages 
observed and prerequisite of extensive base pairing between miRNA:target, miRNA-
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mediated mRNA cleavages were regarded to be exceptional rather than a general rule for 
mammalian gene silencing machinery [125,126,127]. We felt the detection methods used 
in those studies, i.e., 5’-RACE, PARE, Ribosome profiling, lacked the necessary 
sensitivity to address the short lived nature of mRNA intermediates in detail especially 
when there were only small portion of mRNA cleavages overlapped among those reports. 
With improved detecting methods, those few cases of miRNA cleavages could just be the 
tip of iceberg.  
     miRNA-target interactions also stimulate miRNA degradation. It has been reported 
that pairing between miRNA and targets can induce 3’end degradation of the miRNA, 
which is followed by the addition of non-template uridines [104]. Uridine addition at the 
3’end of miRNAs leads to miRNA destabilization.  
     One of the many challenges for studying mechanism of target regulation by miRNA is 
the limited availability of miRNA-target interaction that has been validated in the 
endogenous context. Often, target predictions are validated by fusing sequence that 
contain the target sites to a reporter gene and assaying for regulation in the presence or 
absence of the cognate miRNA. Here, the natural regulatory context is lost, both at the 
level of the target sequence within its mRNA as well as at the level of cellular context. 
However, it is possible now to identify endogenous miRNA-directed cleavage sites 
through SLA-RT-PCR. Here, we used this method to examine whether Hmga2 mRNA 
was a natural target of let-7 [128]. Hmga2 is a very good system to study endogenous 
miRNA regulation mechanism, which has one perfect seed region base pairing in 5’ UTR 
and seven perfect seed region base pairings to seed region of let-7 in 3’UTR, predicted by 
bioinformatics computer program (Figure 25A and 25B). Additionally, we set out to 
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discover the mechanism by which the target RNA is recognized and cleaved by 
endogenous miRNA in physiological context. In the endogenous context, many factors 
influence the ability of the miRNA targeting at mRNA targets.  
A 
 
B 
 
Figure 25. Bioinformatic prediction of let-7 targets in Hmga2 mRNA. (A) Schematic 
representation of Hmga2 gene targets by let-7 miRNA. (B) Sequence alignment of let-7a 
complementary sites in the 5’UTR and 3’UTR of Hmga2 gene. Seed region (nucleotides 
2 to 7) is highlighted in red. 
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     With the limited miRNA seed region, other factors must influence target site selection 
in the context. i.e. the position and context feature that contribute to target site selection 
and efficiency. AU rich region enhance accessibility to the miRNA complex. In addition, 
target sites tend to avoid sequence immediately after translation stop codon.  
    Hmga2 codes for a chromatin-associated protein, which has no intrinsic transcription 
activity but can regulate transcription by altering the chromatin architecture [129]. 
Hmga2 is normally expressed at low levels in adult tissues; however, over-expression of 
Hmga2 has been detected high expression in human tumors [130]. Let-7 family, one of 
the well-studied of the miRNA families, was first identified in C. elegans [131]. It was 
reported that let-7 acts as a tumor suppressor gene. Bartel et al. reported that the loss of 
let-7 was associated with oncogenic Hmga2 translocations in various human tumors 
[128].  
 
4.2 Methods and Materials 
4.2.1 SLA-RT-PCR for detection cleavage RNA fragments 
    Total RNA was prepared by using TRIzol reagent (Invitrogen, Carlbad, CA) and 
phenol:chloroform according to standard total RNA isolation protocols. RNA was treated 
with DNaseI to eliminate DNA contamination. RNA was reversed transcribed using the 
High Capacity Reverse Transcription kit (Applied Biosystem) in combination with a 
series of stem-loop RT-primers. Briefly, 10 µL RNA (50 ng) was supplemented with 2 
µL RT primer (10 µM), 2 µL RT buffer (10 ×), 1 µL multiscribe reverse transcriptase, 
0.8 µL dNTP mix (100 mM) in a total reaction volume of 20 µL. To increase reverse 
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transcription efficiency,  a pulsed RT reaction was performed (60 cycles of 18 °C for 1 
min and 37 °C for 1 second, followed by 60 cycles of 20 °C for 1min and 37 °C for 1 
second, and then 37 °C 30min, 42 °C 20 min, 85 °C 10min).   
    For each cDNA sample, RT product was diluted 500 fold. PCR reactions were 
conducted as follows: 95 °C for 5 min followed by 35 cycles of 95 °C for 15 s, 61 °C for 
30s, and 37 °C for 30s, then chased for 95°C for 15 s, 58 °C for 2 min, and 37 °C for 2 
min. 
 
4.2.2 Western blotting analysis 
    Proteins were resolved with 7.5% or 15% SDS-polyacrylamide gels and transferred to 
Immobilon-P transfer membrane (Millipore). Primary antibodies used were rabbit anti-
Ago2 (Cell-Signaling), rabbit anti-GW182 (Novus), mouse anti-Hmga2 (Cell-Signaling), 
rabbit TUTase-2 (Abnova), goat TUTase-3 (Abcam), and mouse anti-β-actin (Clontech).  
 
4.2.3 Let-7 target plasmid construction 
     Dual let-7 target sequences were cloned into the 3’ UTR of the GFP gene in the vector 
pLJT214. The first let-7 targets and the second let-7 target sequence were cloned directly 
into the unique NheI-EcoRI and the unique BglII-xhoI restriction sites of the vector, 
respectively 
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4.3 Results  
4.3.1 Let-7 mediated Hmga2 mRNA cleavage by the influence of Hmga2 mRNA 
context 
    Total RNA from H1299 cells was chosen for this analysis. A collection of SL RT 
primers with 6 nt probe matching along Hmga2 let-7 target sequence were designed to 
detect the accumulation of cleaved mRNA fragments around 8 let-7 target sites. PCR 
amplicons were analyzed on agarose electrophoresis gels in the order of let-7 miRNA 
target sequence at 3’ - 5’ direction. Amplicon intensity of each PCR reaction represented 
the relative abundance of 5’ fragment detected by a SL-RT primer respectively. We 
detected these 8 predicted let-7 target sites have different cleavage efficiency, indicating 
the other characteristics except 7 nt seed match help specify targeting. Importantly, the 
context feature of target sites within an mRNA has been associated with how well it is 
recognized and regulated by the miRISC, which may help explain the variable efficiency 
in let-7 cleavage Hmga2 target mRNA.   
     The predicted 1# target site in 3’UTR, which is in the 15nt from stop codon, could no 
longer cleaved by let-7 (Figure 27). It reaches the same conclusion that targets sites tend 
to avoid sequence immediately after the translational stop codon, which is bound by the 
ribosome. It suggested that miRISC might utilize the translation machinery to scan 
mRNAs, as miRISC was found to be associated with ribosomal factors and was displaced 
by the ribosome when the stop codon approached the ribosome A site. In addition, the 
predicted -1# target site in 5’UTR can be cleaved by let-7 with the reduced efficacy 
(Figure 26). The majority of miRNA target sites are reported in the 3’UTR of mRNAs, 
which are more effective than those in either 5’ UTRs or ORF. The reduced efficacy of 
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miRNA target sites in 5’UTR or ORF may be attributed to displacement of the miRISC 
by ribosomes in 5’UTR and ORF, as miRISC passes from the cap to the start codon and 
finally to stop codon by translocating ribosomes.  
      We detected the accumulation of let-7 cleaved 5’ fragments around target sites -1# -
7# (Figure 26-33). SLA-RT-PCR revealed similar pattern around miRNA target sites, 
which have elevated bands at central bulge, 3’ complimentary pairing region, 3’ adjacent 
and 5’ adjacent region. Seed region is the only region without cleaved 5’ RNA fragment 
accumulation. However, the target mRNA cleavage mechanisms in these regions are 
different. Ago2 retains the ability to catalyze site-specific miRNA directed 
endonucleolytic target cleavage, which requires the Watson–Crick pairing between 
miRNA and target. The accumulation on 3’ adjacent region is because the let-7 target 
sites block 3’-5’ degradation, and the increased band on 5’ adjacent region is due to the 
3’-5’ degradation caused from the 3’ complimentary pairing region. 
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   5’-    UGAGGUAGUAGGUUGUAUAGUU  -3’  
          |||||||:|:|  |   ||  
 3’–CUCCACCUCCAUCGUUCUCCUCCUCCCUUCGCU-
5’ 
    |||||| 
 
 
HMGA2 Target 
 Stem loop RT probe (5’–3’) RNA Fragment Detected(3’–5’) 
C1  SL- GAGGTG CUCCACCUCCAUCGUUCUCCUCCUCCCUUCGC 
U2   SL- AGGTGG  UCCACCUCCAUCGUUCUCCUCCUCCCUUCGC 
C3    SL- GGTGGA   CCACCUCCAUCGUUCUCCUCCUCCCUUCGC 
C4     SL- GTGGAG    CACCUCCAUCGUUCUCCUCCUCCCUUCGC 
A5      SL- TGGAGG     ACCUCCAUCGUUCUCCUCCUCCCUUCGC 
C6       SL- GGAGGT      CCUCCAUCGUUCUCCUCCUCCCUUCGC 
C7        SL- GAGGTA        CUCCAUCGUUCUCCUCCUCCCUUCGC 
U8         SL- AGGTAG        UCCAUCGUUCUCCUCCUCCCUUCGC 
C9          SL- GGTAGC         CCAUCGUUCUCCUCCUCCCUUCGC 
C10           SL- GTAGCA          CAUCGUUCUCCUCCUCCCUUCGC 
A11            SL- TAGCAA            AUCGUUCUCCUCCUCCCUUCGC 
U12             SL- AGCAAG             UCGUUCUCCUCCUCCCUUCGC 
C13              SL- GCAAGA             CGUUCUCCUCCUCCCUUCGC 
G14               SL- CAAGAG              GUUCUCCUCCUCCCUUCGC 
U15                SL- AAGAGG               UUCUCCUCCUCCCUUCGC 
U16                 SL- AGAGGA                UCUCCUCCUCCCUUCGC 
C17                  SL- GAGGAG                 CUCCUCCUCCCUUCGC 
U18                   SL- AGGAGG                  UCCUCCUCCCUUCGC 
C19                    SL- GGAGGA                   CCUCCUCCCUUCGC 
C20                     SL- GAGGAG                    CUCCUCCCUUCGC 
U21                      SL- AGGAGG                     UCCUCCCUUCGC 
C22                       SL- GGAGGG                      CCUCCCUUCGC 
C23                        SL- GAGGGA                       CUCCCUUCGC 
U24                         SL- AGGGAA                        UCCCUUCGC 
C25                          SL- GGGAAG                         CCCUUCGC 
C26                           SL- GGAAGC                          CCUUCGC 
C27                            SL- GAAGCG                           CUUCGC 
U28                             SL- AAGCGA                            UUCGC 
 
Figure 26. Detection of let-7 miRNA directed Hmga2 cleavage at target site 1# in 5’ 
UTR by SLA-RT-PCR. All PCR products were run in agarose gels and mapped to the 
SLA-RT primers list and detected corresponding RNA fragment 
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position expected to let-7-directed Hmga2 cleavage. The expected PCR size was marked 
with arrow at the left side of agarose gel. miRNA and target site seed region was 
highlighted with red. Each SLA-RT primer and corresponding RNA cleaved fragment 
which could be detected was illustrated in the table.  
 
 
   5’-     UGAGGUAGUAGGUUGUAUAGUU  -3’  
           ||||||||::|:| |:||| 
 3’–ACGACGACUCCAUCUUUAGCUUGCAACCGCGG-
5’ 
    |||||| 
 
 
HMGA2 Target 
 Stem loop RT probe (5’–3’) RNA Fragment Detected(3’–5’) 
A1 SL- TGCTGC ACGACGACUCCAUCUUUAGCUUGCAACCGCGG 
C2  SL- GCTGCT   CGACGACUCCAUCUUUAGCUUGCAACCGCGG 
G3   SL- CTGCTG    GACGACUCCAUCUUUAGCUUGCAACCGCGG 
A4    SL- TGCTGA     ACGACUCCAUCUUUAGCUUGCAACCGCGG 
C5     SL- GCTGAG      CGACUCCAUCUUUAGCUUGCAACCGCGG 
G6      SL- CTGAGG       GACUCCAUCUUUAGCUUGCAACCGCGG 
A7       SL- TGAGGT        ACUCCAUCUUUAGCUUGCAACCGCGG 
C8        SL- GAGGTA        CUCCAUCUUUAGCUUGCAACCGCGG 
U9         SL- AGGTAG          UCCAUCUUUAGCUUGCAACCGCGG 
C10          SL- GGTAGA           CCAUCUUUAGCUUGCAACCGCGG 
C11           SL- GTAGAA            CAUCUUUAGCUUGCAACCGCGG 
A12            SL- TAGAAA              AUCUUUAGCUUGCAACCGCGG 
U13             SL- AGAAAT               UCUUUAGCUUGCAACCGCGG 
C14              SL- GAAATC                CUUUAGCUUGCAACCGCGG 
U15               SL- AAATCG                 UUUAGCUUGCAACCGCGG 
U16                SL- AATCGA                  UUAGCUUGCAACCGCGG 
U17                 SL- ATCGAA                     UAGCUUGCAACCGCGG 
A18                  SL- TCGAAC                      AGCUUGCAACCGCGG 
G19                   SL- CGAACG                       GCUUGCAACCGCGG  
C20                    SL- GAACGT                        CUUGCAACCGCGG 
U21                     SL- AACGTT                         UUGCAACCGCGG 
U22                      SL- ACGTTG                            UGCAACCGCGG 
G23                       SL- CGTTGG                             GCAACCGCGG 
C24                        SL- GTTGGC                             CAACCGCGG 
A25                         SL- TTGGCG                           AACCGCGG 
A26                          SL- TTGGCG                            ACCGCGG 
C27                           SL- TGGCGC                             CCGCGG 
SLA-RT primers list and detected corresponding RNA fragment  
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C28                            SL- GGCGCC                             CGCGG 
 
Figure 27. Detection of let-7 miRNA directed Hmga2 cleavage at target site 1# in 3’ 
UTR by SLA-RT-PCR. All PCR products were run in agarose gels and mapped to the 
position expected to let-7-directed Hmga2 cleavage. The expected PCR size was marked 
with arrow at the left side of agarose gel. miRNA and target site seed region was 
highlighted with red. Each SLA-RT primer and corresponding RNA cleaved fragment 
which could be detected was illustrated in the table. 
 
 
   5’-    UGAGGUAGUAGGUUGUAUAGUU  -3’  
          ||||||:  ||| | :|| | 
3’–AAUUAAACUCCAUUCACCAUAAGUCCAGAAAGU-
5’ 
   |||||| 
 
 
HMGA2 Target 
 Stem loop RT probe (5’–3’) RNA Fragment Detected(3’–5’) 
A1 SL-TTAATT AAUUAAACUCCAUUCACCAUAAGUCCAGAAAG 
A2  SL-TAATTT  AUUAAACUCCAUUCACCAUAAGUCCAGAAAG 
U3   SL-AATTTG   UUAAACUCCAUUCACCAUAAGUCCAGAAAG 
U4    SL-ATTTGA    UAAACUCCAUUCACCAUAAGUCCAGAAAG   
A5     SL-TTTGAG     AAACUCCAUUCACCAUAAGUCCAGAAAG   
A6      SL-TTGAGG      AACUCCAUUCACCAUAAGUCCAGAAAG  
A7       SL-TGAGGT       ACUCCAUUCACCAUAAGUCCAGAAAG 
C8        SL-GAGGTA        CUCCAUUCACCAUAAGUCCAGAAAG 
U9         SL-AGGTAA         UCCAUUCACCAUAAGUCCAGAAAG 
C10          SL-GGTAAG          CCAUUCACCAUAAGUCCAGAAAG    
C11           SL-GTAAGT           CAUUCACCAUAAGUCCAGAAAG 
A12            SL-TAAGTG            AUUCACCAUAAGUCCAGAAAG 
U13             SL-AAGTGG             UUCACCAUAAGUCCAGAAAG 
U14              SL-AGTGGT              UCACCAUAAGUCCAGAAAG 
C15               SL-GTGGTA               CACCAUAAGUCCAGAAAG 
A16 SL-TGGTAT                ACCAUAAGUCCAGAAAG 
C17 SL-GGTATT                 CCAUAAGUCCAGAAAG 
C18                  SL-GTATTC                  CAUAAGUCCAGAAAG 
A19                   SL-TATTCA                   AUAAGUCCAGAAAG 
U20                    SL-ATTCAG                    UAAGUCCAGAAAG 
SLA-RT primers list and detected corresponding RNA fragment  
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A21                     SL-TTCAGG                     AAGUCCAGAAAG 
A22 SL-TCAGGT                      AGUCCAGAAAG 
G23                       SL-CAGGTC                       GUCCAGAAAG 
U24                        SL-AGGTCT                               UCCAGAAAG 
C25                         SL-GGTCTT                         CCAGAAAG 
C26                          SL-GTCTTT                          CAGAAAG 
A27                           SL-TCTTTC                           AGAAAG 
G28                            SL-CTTTCA                            GAAAG 
 
Figure 28. Detection of let-7 miRNA directed Hmga2 cleavage at target site 2# in 3’ 
UTR by SLA-RT-PCR. All PCR products were run in agarose gels and mapped to the 
position expected to let-7-directed Hmga2 cleavage. The expected PCR size was marked 
with arrow at the left side of agarose gel. miRNA and target site seed region was 
highlighted with red. Each SLA-RT primer and corresponding RNA cleaved fragment 
which could be detected was illustrated in the table. 
 
 
   5’-    UGAGGUAGUA--GG-UUGU----AUAGUU3’  
          |||||||||  |: | ||    |||  | 
3’–GUAAGUUCUCCAUCAUAACUCAUCACCCCUAUAUA-5’ 
   |||||| 
 
 
HMGA2 Target 
 Stem loop RT probe (5’–3’) RNA Fragment Detected(3’–5’) 
G1 SL-CATTCA GUAAGUUCUCCAUCAUAACUCAUCACCCCUAUAUA 
U2  SL-ATTCAA UAAGUUCUCCAUCAUAACUCAUCACCCCUAUAUA 
A3   SL-TTCAAG AAGUUCUCCAUCAUAACUCAUCACCCCUAUAUA 
A4    SL-TCAAGA AGUUCUCCAUCAUAACUCAUCACCCCUAUAUA 
G5     SL-CAAGAG GUUCUCCAUCAUAACUCAUCACCCCUAUAUA 
U6      SL-AAGAGG UUCUCCAUCAUAACUCAUCACCCCUAUAUA 
U7 SL-AGAGGT UCUCCAUCAUAACUCAUCACCCCUAUAUA 
C8 SL-GAGGTA CUCCAUCAUAACUCAUCACCCCUAUAUA 
U9 SL-AGGTAG UCCAUCAUAACUCAUCACCCCUAUAUA 
C10          SL-GGTAGT CCAUCAUAACUCAUCACCCCUAUAUA 
C11 SL-GTAGTA CAUCAUAACUCAUCACCCCUAUAUA 
A12 SL-TAGTAT AUCAUAACUCAUCACCCCUAUAUA 
SLA-RT primers list and detected corresponding RNA fragment  
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U13 SL-AGTATT UCAUAACUCAUCACCCCUAUAUA 
C14 SL-GTATTG CAUAACUCAUCACCCCUAUAUA 
A15 SL-TATTGA AUAACUCAUCACCCCUAUAUA 
U16 SL-ATTGAG UAACUCAUCACCCCUAUAUA 
A17 SL-TTGAGT AACUCAUCACCCCUAUAUA 
A18 SL-TGAGTA ACUCAUCACCCCUAUAUA 
C19                  SL-GAGTAG CUCAUCACCCCUAUAUA 
U20 SL-AGTAGT UCAUCACCCCUAUAUA 
C21 SL-GTAGTG CAUCACCCCUAUAUA 
A22 SL-TAGTGG AUCACCCCUAUAUA 
U23 SL-AGTGGG UCACCCCUAUAUA 
C24 SL-GTGGGG CACCCCUAUAUA 
A25 SL-TGGGGA ACCCCUAUAUA 
C26 SL-GGGGAT CCCCUAUAUA 
C27 SL-GGGATA CCCUAUAUA 
C28 SL-GGATAT CCUAUAUA 
C29 SL-GATATA CUAUAUA 
U30 SL-ATATAT UAUAUA 
A31 SL-TATATT AUAUA 
U32                              SL-ATATTG UAUA 
A33                               SL-ATATTG AUA 
U34 SL-TATTGC UA 
A35                                 SL-ATTGCA A 
 
Figure 29. Detection of let-7 miRNA directed Hmga2 cleavage at target site 3# in 3’ 
UTR by SLA-RT-PCR. All PCR products were run in agarose gels and mapped to the 
position expected to let-7-directed Hmga2 cleavage. The expected PCR size was marked 
with arrow at the left side of agarose gel. miRNA and target site seed region was 
highlighted with red. Each SLA-RT primer and corresponding RNA cleaved fragment 
which could be detected was illustrated in the table. 
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   5’-     UGAGGUAGUAGGUUGUAUAGUU  -3’  
           ||||||   : ||| |  || 
 3’–AAGUAAACUCCAUGUCUGAACCUCCCAUU-5’ 
    |||||| 
 
 
HMGA2 Target 
 Stem loop RT probe (5’–3’) RNA Fragment Detected(3’–5’) 
A1 SL- TTCATT AAGUAAACUCCAUGUCUGAACCUCCCAUU 
A2 SL- TCATTT AGUAAACUCCAUGUCUGAACCUCCCAUU 
G3   SL- CATTTG GUAAACUCCAUGUCUGAACCUCCCAUU 
U4    SL- ATTTGA UAAACUCCAUGUCUGAACCUCCCAUU 
A5 SL- TTTGAG     AAACUCCAUGUCUGAACCUCCCAUU 
A6 SL- TTGAGG AACUCCAUGUCUGAACCUCCCAUU 
A7 SL- TGAGGT ACUCCAUGUCUGAACCUCCCAUU     
C8 SL- GAGGTA CUCCAUGUCUGAACCUCCCAUU 
U9 SL- AGGTAC UCCAUGUCUGAACCUCCCAUU 
C10 SL- GGTACA CCAUGUCUGAACCUCCCAUU 
C11          SL- GTACAG CAUGUCUGAACCUCCCAUU 
A12 SL- TACAGA AUGUCUGAACCUCCCAUU 
U13 SL- ACAGAC UGUCUGAACCUCCCAUU 
G14  SL- CAGACT GUCUGAACCUCCCAUU 
U15 SL- AGACTT UCUGAACCUCCCAUU 
C16 SL- GACTTG CUGAACCUCCCAUU 
U17 SL- ACTTGG UGAACCUCCCAUU 
G18 SL- CTTGGA GAACCUCCCAUU 
A19 SL- TTGGAG AACCUCCCAUU 
A20 SL- TGGAGG ACCUCCCAUU 
C21 SL- GGAGGG CCUCCCAUU 
C22 SL- GAGGGT                    CUCCCAUU 
U23 SL- AGGGTA UCCCAUU 
C24 SL- GGGTAA CCCAUU 
C25 SL- GGTAAT CCAUU 
C26 SL- GTAATA CAUU 
A27 SL- TAATAT AUU 
U28 SL- AATATT UU 
U29 SL- ATATTT  U 
 
SLA-RT primers list and detected corresponding RNA fragment  
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Figure 30. Detection of let-7 miRNA directed Hmga2 cleavage at target site 4# in 3’ 
UTR by SLA-RT-PCR. All PCR products were run in agarose gels and mapped to the 
position expected to let-7-directed Hmga2 cleavage. The expected PCR size was marked 
with arrow at the left side of agarose gel. miRNA and target site seed region was 
highlighted with red. Each SLA-RT primer and corresponding RNA cleaved fragment 
which could be detected was illustrated in the table. 
 
 
     5’-  UGAGGUAGUAGGUUGUAUAGUU  -3’  
          |||||||    |||:||||: 
 3’–UCAGACCUCCAUCCAGAAACGUUCAGUU-5’ 
    |||||| 
 
 
HMGA2 Target 
 Stem loop RT probe (5’–3’) RNA Fragment Detected(3’–5’) 
U1 SL- AGTCTG UCAGACCUCCAUCCAGAAACGUUCAGUU 
C2  SL- GTCTGG CAGACCUCCAUCCAGAAACGUUCAGUU 
A3   SL- TCTGGA AGACCUCCAUCCAGAAACGUUCAGUU 
G4    SL- CTGGAG GACCUCCAUCCAGAAACGUUCAGUU 
A5 SL- TGGAGG ACCUCCAUCCAGAAACGUUCAGUU 
C6      SL- GGAGGT CCUCCAUCCAGAAACGUUCAGUU 
C7 SL- GAGGTA CUCCAUCCAGAAACGUUCAGUU 
U8 SL- AGGTAG UCCAUCCAGAAACGUUCAGUU 
C9         SL- GGTAGG CCAUCCAGAAACGUUCAGUU 
C10 SL- GTAGGT CAUCCAGAAACGUUCAGUU 
A11 SL- TAGGTC AUCCAGAAACGUUCAGUU 
U12            SL- AGGTCT UCCAGAAACGUUCAGUU 
C13             SL- GGTCTT CCAGAAACGUUCAGUU 
C14              SL- GTCTTT CAGAAACGUUCAGUU 
A15               SL- TCTTTG AGAAACGUUCAGUU 
G16                SL- CTTTGC GAAACGUUCAGUU 
A17                 SL- TTTGCA AAACGUUCAGUU 
A18                  SL- TTGCAA AACGUUCAGUU 
A19                   SL- TGCAAG ACGUUCAGUU 
C20                    SL- GCAAGT CGUUCAGUU 
G21                     SL- CAAGTC GUUCAGUU 
U22                      SL- AAGTCA UUCAGUU 
U23                       SL- AGTCAA UCAGUU 
SLA-RT primers list and detected corresponding RNA fragment  
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C24                        SL- GTCAAT CAGUU 
A25                         SL- TCAATT AGUU 
G26                          SL- CAATTA                      GUU 
U27                           SL- AATTAG UU 
U28                            SL- ATTAGT                        U 
 
Figure 31. Detection of let-7 miRNA directed Hmga2 cleavage at target site 5# in 3’ 
UTR by SLA-RT-PCR. All PCR products were run in agarose gels and mapped to the 
position expected to let-7-directed Hmga2 cleavage. The expected PCR size was marked 
with arrow at the left side of agarose gel. miRNA and target site seed region was 
highlighted with red. Each SLA-RT primer and corresponding RNA cleaved fragment 
which could be detected was illustrated in the table. 
 
 
   5’-    UGAGGUAGUAGGUUGUAUAGUU  -3’  
          |||||||||:|  |   ||  
 3’–UGAAUUCUCCAUCAUCACACAAAACUAA-5’ 
    |||||| 
 
 
HMGA2 Target 
 Stem loop RT probe (5’–3’) RNA Fragment Detected(3’–5’) 
U1 SL- ACTTAA UGAAUUCUCCAUCAUCACACAAAACUAA  
G2  SL- CTTAAG  GAAUUCUCCAUCAUCACACAAAACUAA 
A3   SL- TTAAGA   AAUUCUCCAUCAUCACACAAAACUAA 
A4    SL- TAAGAG    AUUCUCCAUCAUCACACAAAACUAA 
U5     SL- AAGAGG     UUCUCCAUCAUCACACAAAACUAA 
U6      SL- AGAGGT      UCUCCAUCAUCACACAAAACUAA 
C7       SL- GAGGTA       CUCCAUCAUCACACAAAACUAA 
U8        SL- AGGTAG        UCCAUCAUCACACAAAACUAA 
C9         SL- GGTAGT         CCAUCAUCACACAAAACUAA 
C10          SL- GTAGTA          CAUCAUCACACAAAACUAA 
A11           SL- TAGTAG           AUCAUCACACAAAACUAA 
U12            SL- AGTAGT            UCAUCACACAAAACUAA 
C13             SL- GTAGTG             CAUCACACAAAACUAA 
A14              SL- TAGTGT              AUCACACAAAACUAA 
U15               SL- AGTGTG               UCACACAAAACUAA 
C16                SL- GTGTGT                CACACAAAACUAA 
SLA-RT primers list and detected corresponding RNA fragment  
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A17                 SL- TGTGTT                 ACACAAAACUAA 
C18                  SL- GTGTTT                  CACAAAACUAA 
A19                   SL- TGTTTT                   ACAAAACUAA 
C20                    SL- GTTTTG                    CAAAACUAA 
A21                     SL- TTTTGA                     AAAACUAA 
A22                      SL- TTTGAT                      AAACUAA 
A23                       SL- TTGATT                       AACUAA 
A24                        SL- TGATTG                        ACUAA 
C25                         SL- GATTGT                         CUAA 
U26                          SL- ATTGTA                          UAA 
A27                           SL- TTGTAC                           AA 
A28                            SL- TGTACA                            A 
 
Figure 32. Detection of let-7 miRNA directed Hmga2 cleavage at target site 6# in 3’ 
UTR by SLA-RT-PCR. All PCR products were run in agarose gels and mapped to the 
position expected to let-7-directed Hmga2 cleavage. The expected PCR size was marked 
with arrow at the left side of agarose gel. miRNA and target site seed region was 
highlighted with red. Each SLA-RT primer and corresponding RNA cleaved fragment 
which could be detected was illustrated in the table. 
 
 
    5’-    UGAGGUAGUA--GGUUGUAUAGUU  -3’  
           ||||||||   ||   ||  
 3’–CUUUUUACUCCAUAUGACCCUGAAUUCUCCAUC-5’ 
    |||||| 
 
 
HMGA2 Target 
 Stem loop RT probe (5’–3’) RNA Fragment Detected(3’–5’) 
C1 SL- GAAAAA CUUUUUACUCCAUAUGACCCUGAAUUCUCCAUC  
U2  SL- AAAAAT  UUUUUACUCCAUAUGACCCUGAAUUCUCCAUC 
U3   SL- AAAATG   UUUUACUCCAUAUGACCCUGAAUUCUCCAUC 
U4    SL- AAATGA    UUUACUCCAUAUGACCCUGAAUUCUCCAUC 
U5     SL- AATGAG     UUACUCCAUAUGACCCUGAAUUCUCCAUC 
U6      SL- ATGAGG      UACUCCAUAUGACCCUGAAUUCUCCAUC 
A7       SL- TGAGGT       ACUCCAUAUGACCCUGAAUUCUCCAUC 
C8        SL- GAGGTA        CUCCAUAUGACCCUGAAUUCUCCAUC 
U9         SL- AGGTAT         UCCAUAUGACCCUGAAUUCUCCAUC 
C10          SL- GGTATA          CCAUAUGACCCUGAAUUCUCCAUC 
C11           SL- GTATAC           CAUAUGACCCUGAAUUCUCCAUC 
A12            SL- TATACT            AUAUGACCCUGAAUUCUCCAUC 
SLA-RT primers list and detected corresponding RNA fragment  
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U13             SL- ATACTG             UAUGACCCUGAAUUCUCCAUC 
A14              SL- TACTGG              AUGACCCUGAAUUCUCCAUC 
U15               SL- ACTGGG               UGACCCUGAAUUCUCCAUC 
G16                SL- CTGGGA                GACCCUGAAUUCUCCAUC 
A17                 SL- TGGGAC                 ACCCUGAAUUCUCCAUC 
C18                  SL- GGGACT                  CCCUGAAUUCUCCAUC 
C19                   SL- GGACTT                   CCUGAAUUCUCCAUC 
C20                    SL- GACTTA                    CUGAAUUCUCCAUC 
U21                     SL- ACTTAA                     UGAAUUCUCCAUC 
G22                      SL- CTTAAG                      GAAUUCUCCAUC 
A23                       SL- TTAAGA                       AAUUCUCCAUC 
A24                        SL- TAAGAG                        AUUCUCCAUC 
U25                         SL- AAGAGG                         UUCUCCAUC 
U26                          SL- AGAGGT                          UCUCCAUC 
C27                           SL- GAGGTA                           CUCCAUC 
U28                            SL- AGGTAG                            UCCAUC 
C29                             SL- GGTAGT                             CCAUC 
C30                              SL- GTAGTA                              CAUC 
A31                               SL- TAGTAG                               AUC 
U32                                SL- AGTAGT                                UC 
C33                                 SL- GTAGTG                                 C 
 
Figure 33. Detection of let-7 miRNA directed Hmga2 cleavage at target site 7# in 3’ 
UTR by SLA-RT-PCR. All PCR products were run in agarose gels and mapped to the 
position expected to let-7-directed Hmga2 cleavage. The expected PCR size was marked 
with arrow at the left side of agarose gel. miRNA and target site seed region was 
highlighted with red. Each SLA-RT primer and corresponding RNA cleaved fragment 
which could be detected was illustrated in the table. 
 
4.3.2 U-Tract added onto the exposed 3’ end of the cleaved 5’-fragment of Hmga2 
target 
     RISC-generated products are eventually degraded by exoribonucleases: Xrn1, a 5’-3′ 
exonuclease, and exosome, a 3-5′multisubunit exonuclease. Interestingly, we recognized 
an unexpected blank out in seed region, which do not have 3’-5’degradation. We then 
asked if there is 3’ end modification at the end of seed region after cleavage by let-7, 
which block 3’- 5’ degradation in the seed region. Nontemplated oligouridine were post-
transcriptionally added to miRNA cleaved 5’ fragments as reported by Shen [132]. To 
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test if oligouridines were added to the 5’ fragments accumulated around let-7 target sites 
on Hmga2 mRNA, we modified SL-RT primers with addition of a number of adenosines 
at the 5’ end of primer probe to match possible nontemplated oligouridines at the 3’ end 
of cleaved RNA fragments (Figure 34). 
 
Figure 34. SLA-RT primers with addition of a number of adenosines at the 5’ end to 
detect possible nontemplated oligouridines at the 3’ end of cleaved RNA fragments.  
 
   Total RNA from H1299 cells were tested with two sets of oligouridine detecting SL-RT 
primers: SLA-RT primers and SLA-8U+RT primers (Figure 35-39). 8U-RT-PCR bands 
increased in 3’ adjacent region, the end in seed region, and the 3’ complimentary pairing 
region. These U sequences were not found in the genome, so they must have been added 
after cleavage by let-7. The weak amplicon blocks in unmodified form in Figure 26-33 
disappeared from oligouridylated groups (Figure 35-39). The drastically increased RNA 
fragments in various length of oligouridylated form over unmodified form indicated that 
oligouridine modification triggered accumulation rather than immediate degradation of 
miRNA cleaved RNA fragments.  
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     5’-  UGAGGUAGUAGGUUGUAUAGUU  -3’  
          |||||||    |||:||||: 
 3’–UCAGACCUCCAUCCAGAAACGUUCAGUU-5’ 
    |||||| 
 
 
HMGA2 Target 
 Regular Stem loop RT probe (5’–3’) 8U-Stem loop RT probe (5’–3’) 
U1 SL- AGTCTG SL- AAAAAAAAGTCTG 
C2  SL- GTCTGG  SL- AAAAAAAAGTCTGG 
A3   SL- TCTGGA   SL- AAAAAAAATCTGGA 
G4    SL- CTGGAG    SL- AAAAAAAACTGGAG 
A5 SL- TGGAGG SL- AAAAAAAATGGAGG 
C6      SL- GGAGGT      SL- AAAAAAAAGGAGGT 
C7 SL- GAGGTA SL- AAAAAAAAGAGGTA 
U8 SL- AGGTAG SL- AAAAAAAAAGGTAG 
C9         SL- GGTAGG         SL- AAAAAAAAGGTAGG 
C10 SL- GTAGGT SL- AAAAAAAAGTAGGT 
A11 SL- TAGGTC SL- AAAAAAAATAGGTC 
U12            SL- AGGTCT            SL- AAAAAAAAAGGTCT 
C13             SL- GGTCTT             SL- AAAAAAAAGGTCTT 
C14              SL- GTCTTT              SL- AAAAAAAAGTCTTT 
A15               SL- TCTTTG               SL- AAAAAAAATCTTTG 
G16                SL- CTTTGC                SL- AAAAAAAACTTTGC 
A17                 SL- TTTGCA                 SL- AAAAAAAATTTGCA 
A18                  SL- TTGCAA                  SL- AAAAAAAATTGCAA 
A19                   SL- TGCAAG                   SL- AAAAAAAATGCAAG 
C20                    SL- GCAAGT                    SL- AAAAAAAAGCAAGT 
G21                     SL- CAAGTC                     SL- AAAAAAAACAAGTC 
U22                      SL- AAGTCA                      SL- AAAAAAAAAAGTCA 
U23                       SL- AGTCAA                       SL- AAAAAAAAAGTCAA 
C24                        SL- GTCAAT                        SL- AAAAAAAAGTCAAT 
A25                         SL- TCAATT                         SL- AAAAAAAATCAATT 
G26                          SL- CAATTA                          SL- AAAAAAAACAATTA 
U27                           SL- AATTAG                           SL- AAAAAAAAAATTAG 
U28                            SL- ATTAGT                            SL- AAAAAAAAATTAGT 
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Figure 35. let-7 miRNA directed uridylation of cleavage fragment at target site 5# in 
3’UTR. All PCR products were run in agarose gels and mapped to the position expected 
to let-7-directed Hmga2 cleavage. RNA was tested with two sets of SLA-RT primers: 
SLA-RT primers and SLA-8U-RT primers, which listed in the table. 8U-RT-PCR bands 
increased in 3’ adjacent region (highlighted with blue), the end in seed region 
(highlighted with red), and the 3’ complimentary pairing region (highlighted with red). 
The expected PCR size was marked with arrow at the left side of agarose gel. miRNA 
and target site seed region was highlighted with red. 
 
   5’-   UGAGGUAGUAGGUUGUAUAGUU  -3’  
         |||||||:|:|  |   ||  
3’–CUCCACCUCCAUCGUUCUCCUCCUCCCUUCGCU-5’ 
   |||||| 
 
 
HMGA2 Target 
 Regular Stem loop RT probe (5’–3’) 8U-Stem loop RT probe (5’–3’) 
C1 SL- GAGGTG SL-AAAAAAAAGAGGTG 
U2  SL- AGGTGG  SL-AAAAAAAAAGGTGG 
C3   SL- GGTGGA   SL-AAAAAAAAGGTGGA 
C4    SL- GTGGAG    SL-AAAAAAAAGTGGAG 
A5     SL- TGGAGG     SL-AAAAAAAATGGAGG 
C6      SL- GGAGGT      SL-AAAAAAAAGGAGGT 
C7       SL- GAGGTA        SL-AAAAAAAAGAGGTA  
U8        SL- AGGTAG        SL-AAAAAAAAAGGTAG 
C9         SL- GGTAGC         SL-AAAAAAAAGGTAGC 
C10          SL- GTAGCA          SL-AAAAAAAAGTAGCA 
A11           SL- TAGCAA            SL-AAAAAAAATAGCAA  
U12            SL- AGCAAG             SL-AAAAAAAAAGCAAG  
C13             SL- GCAAGA             SL-AAAAAAAAGCAAGA 
G14              SL- CAAGAG              SL-AAAAAAAACAAGAG 
U15               SL- AAGAGG               SL-AAAAAAAAAAGAGG 
U16                SL- AGAGGA                SL-AAAAAAAAAGAGGA 
C17                 SL- GAGGAG                 SL-AAAAAAAAGAGGAG 
U18                  SL- AGGAGG                  SL-AAAAAAAAAGGAGG 
C19                   SL- GGAGGA                   SL-AAAAAAAAGGAGGA 
C20                    SL- GAGGAG                    SL-AAAAAAAAGAGGAG 
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U21                     SL- AGGAGG                     SL-AAAAAAAAAGGAGG 
C22                      SL- GGAGGG                      SL-AAAAAAAAGGAGGG 
C23                       SL- GAGGGA                       SL-AAAAAAAAGAGGGA 
U24                        SL- AGGGAA                        SL-AAAAAAAAAGGGAA 
C25                         SL- GGGAAG                         SL-AAAAAAAAGGGAAG 
C26                          SL- GGAAGC                          SL-AAAAAAAAGGAAGC 
C27                           SL- GAAGCG                           SL-AAAAAAAAGAAGCG 
U28                            SL- AAGCGA                            SL-AAAAAAAAAAGCGA 
Figure 36. let-7 miRNA directed uridylation of cleavage fragment at target site -1# in 
5’UTR. All PCR products were run in agarose gels and mapped to the position expected 
to let-7-directed Hmga2 cleavage. RNA was tested with two sets of SLA-RT primers: 
SLA-RT primers and SLA-8U-RT primers, which listed in the table. 8U-RT-PCR bands 
increased in 3’ adjacent region (highlighted with blue), the end in seed region 
(highlighted with red), and the 3’ complimentary pairing region (highlighted with red). 
The expected PCR size was marked with arrow at the left side of agarose gel. miRNA 
and target site seed region was highlighted with red. 
 
 
 
  5’-    UGAGGUAGUAGGUUGUAUAGUU  -3’  
          ||||||:  ||| | :|| | 
3’–AAUUAAACUCCAUUCACCAUAAGUCCA-5’ 
   |||||| 
 
 
HMGA2 Target 
 Regular Stem loop RT probe (5’–3’) 8U-Stem loop RT probe (5’–3’) 
A1 SL-TTAATT SL-AAAAAAAATTAATT 
A2  SL-TAATTT  SL-AAAAAAAATAATTT 
U3   SL-AATTTG   SL-AAAAAAAAAATTTG 
U4    SL-ATTTGA    SL-AAAAAAAAATTTGA 
A5     SL-TTTGAG     SL-AAAAAAAATTTGAG 
A6      SL-TTGAGG      SL-AAAAAAAATTGAGG 
A7       SL-TGAGGT       SL-AAAAAAAATGAGGT 
SLA-RT primers and 8U-SLA-RT primers list 
80 
 
C8        SL-GAGGTA        SL-AAAAAAAAGAGGTA 
U9         SL-AGGTAA         SL-AAAAAAAAAGGTAA 
C10          SL-GGTAAG          SL-AAAAAAAAGGTAAG 
C11           SL-GTAAGT           SL-AAAAAAAAGTAAGT 
A12            SL-TAAGTG            SL-AAAAAAAATAAGTG 
U13             SL-AAGTGG             SL-AAAAAAAAAAGTGG 
U14              SL-AGTGGT              SL-AAAAAAAAAGTGGT 
C15               SL-GTGGTA               SL-AAAAAAAAGTGGTA 
A16 SL-TGGTAT SL-AAAAAAAATGGTAT 
C17 SL-GGTATT SL-AAAAAAAAGGTATT 
C18                  SL-GTATTC                  SL-AAAAAAAAGTATTC 
A19                   SL-TATTCA                   SL-AAAAAAAATATTCA 
U20                    SL-ATTCAG                    SL-AAAAAAAAATTCAG 
A21                     SL-TTCAGG                     SL-AAAAAAAATTCAGG 
A22 SL-TCAGGT SL-AAAAAAAATCAGGT 
G23                       SL-CAGGTC                       SL-AAAAAAAACAGGTC 
U24                        SL-AGGTCT                             SL-AAAAAAAAAGGTCT      
C25                         SL-GGTCTT                         SL-AAAAAAAAGGTCTT 
C26                          SL-GTCTTT                          SL-AAAAAAAAGTCTTT 
A27                           SL-TCTTTC                           SL-AAAAAAAATCTTTC 
G28                            SL-CTTTCA                            SL-AAAAAAAACTTTCA 
Figure 37. let-7 miRNA directed uridylation of cleavage fragment at target site 2# in 
3’UTR. All PCR products were run in agarose gels and mapped to the position expected 
to let-7-directed Hmga2 cleavage. RNA was tested with two sets of SLA-RT primers: 
SLA-RT primers and SLA-8U-RT primers, which listed in the table. 8U-RT-PCR bands 
increased in 3’ adjacent region (highlighted with blue), the end in seed region 
(highlighted with red), and the 3’ complimentary pairing region (highlighted with red). 
The expected PCR size was marked with arrow at the left side of agarose gel. miRNA 
and target site seed region was highlighted with red. 
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   5’-    UGAGGUAGUA--GG-UUGU----AUAGUU3’  
          |||||||||  |: | ||    |||  | 
3’–GUAAGUUCUCCAUCAUAACUCAUCACCCCUAUAUA-5’ 
   |||||| 
 
 
HMGA2 Target 
 Regular Stem loop RT probe (5’–3’) 8U-Stem loop RT probe (5’–3’) 
G1 SL-CATTCA SL-AAAAAAAACATTCA 
U2  SL-ATTCAA  SL-AAAAAAAAATTCAA 
A3   SL-TTCAAG   SL-AAAAAAAATTCAAG 
A4    SL-TCAAGA    SL-AAAAAAAATCAAGA 
G5     SL-CAAGAG     SL-AAAAAAAACAAGAG 
U6      SL-AAGAGG      SL-AAAAAAAAAAGAGG 
U7 SL-AGAGGT SL-AAAAAAAAAGAGGT 
C8 SL-GAGGTA SL-AAAAAAAAGAGGTA 
U9 SL-AGGTAG SL-AAAAAAAAAGGTAG 
C10          SL-GGTAGT          SL-AAAAAAAAGGTAGT 
C11 SL-GTAGTA SL-AAAAAAAAGTAGTA 
A12 SL-TAGTAT SL-AAAAAAAATAGTAT 
U13 SL-AGTATT SL-AAAAAAAAAGTATT 
C14 SL-GTATTG SL-AAAAAAAAGTATTG 
A15 SL-TATTGA SL-AAAAAAAATATTGA 
U16 SL-ATTGAG SL-AAAAAAAAATTGAG 
A17 SL-TTGAGT SL-AAAAAAAATTGAGT 
A18 SL-TGAGTA SL-AAAAAAAATGAGTA 
C19                  SL-GAGTAG                  SL-AAAAAAAAGAGTAG 
U20 SL-AGTAGT SL-AAAAAAAAAGTAGT 
C21 SL-GTAGTG SL-AAAAAAAAGTAGTG 
A22 SL-TAGTGG SL-AAAAAAAATAGTGG 
U23 SL-AGTGGG SL-AAAAAAAAAGTGGG 
C24 SL-GTGGGG SL-AAAAAAAAGTGGGG 
A25 SL-TGGGGA SL-AAAAAAAATGGGGA 
C26 SL-GGGGAT SL-AAAAAAAAGGGGAT 
C27 SL-GGGATA SL-AAAAAAAAGGGATA 
C28 SL-GGATAT SL-AAAAAAAAGGATAT 
C29 SL-GATATA SL-AAAAAAAAGATATA 
U30 SL-ATATAT SL-AAAAAAAAATATAT 
A31 SL-TATATT SL-AAAAAAAATATATT 
U32                              SL-ATATTG                              SL-AAAAAAAAATATTG 
A33                               SL-ATATTG                               SL-AAAAAAAAATATTG 
U34 SL-TATTGC SL-AAAAAAAATATTGC 
A35                                 SL-ATTGCA                                 SL-AAAAAAAAATTGCA 
Figure 38. let-7 miRNA directed uridylation of cleavage fragment at target site 3# in 
3’UTR. All PCR products were run in agarose gels and mapped to the position expected 
to let-7-directed Hmga2 cleavage. RNA was tested with two sets of SLA-RT primers: 
SLA-RT primers and SLA-8U-RT primers, which listed in the table. 8U-RT-PCR bands 
increased in 3’ adjacent region (highlighted with blue), the end in seed region 
SLA-RT primers and 8U-SLA-RT primers list 
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(highlighted with red), and the 3’ complimentary pairing region (highlighted with red). 
The expected PCR size was marked with arrow at the left side of agarose gel. miRNA 
and target site seed region was highlighted with red. 
 
 
   5’-     UGAGGUAGUAGGUUGUAUAGUU  -3’  
           ||||||   : ||| |  || 
 3’–AAGUAAACUCCAUGUCUGAACCUCCCAUU-5’ 
    |||||| 
 
 
HMGA2 Target 
 Regular Stem loop RT probe (5’–3’) 8U-Stem loop RT probe (5’–3’) 
A1 SL- TTCATT SL- AAAAAAAATTCATT 
A2 SL- TCATTT SL- AAAAAAAATCATTT 
G3   SL- CATTTG   SL- AAAAAAAACATTTG 
U4    SL- ATTTGA    SL- AAAAAAAAATTTGA 
A5 SL- TTTGAG SL- AAAAAAAATTTGAG 
A6 SL- TTGAGG SL- AAAAAAAATTGAGG 
A7 SL- TGAGGT SL- AAAAAAAATGAGGT 
C8 SL- GAGGTA SL- AAAAAAAAGAGGTA 
U9 SL- AGGTAC SL- AAAAAAAAAGGTAC 
C10 SL- GGTACA SL- AAAAAAAAGGTACA 
C11          SL- GTACAG          SL- AAAAAAAAGTACAG 
A12 SL- TACAGA SL- AAAAAAAATACAGA 
U13 SL- ACAGAC SL- AAAAAAAAACAGAC 
G14  SL- CAGACT  SL- AAAAAAAACAGACT 
U15 SL- AGACTT SL- AAAAAAAAAGACTT 
C16 SL- GACTTG SL- AAAAAAAAGACTTG 
U17 SL- ACTTGG SL- AAAAAAAAACTTGG 
G18 SL- CTTGGA SL- AAAAAAAACTTGGA 
A19 SL- TTGGAG SL- AAAAAAAATTGGAG 
A20 SL- TGGAGG SL- AAAAAAAATGGAGG 
C21 SL- GGAGGG SL- AAAAAAAAGGAGGG 
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C22 SL- GAGGGT SL- AAAAAAAAGAGGGT 
U23 SL- AGGGTA SL- AAAAAAAAAGGGTA 
C24 SL- GGGTAA SL- AAAAAAAAGGGTAA 
C25 SL- GGTAAT SL- AAAAAAAAGGTAAT 
C26 SL- GTAATA SL- AAAAAAAAGTAATA 
A27 SL- TAATAT SL- AAAAAAAATAATAT 
U28 SL- AATATT SL- AAAAAAAAAATATT 
U29 SL- ATATTT SL- AAAAAAAAATATTT 
Figure 39. let-7 miRNA directed uridylation of cleavage fragment at target site 4# in 
3’UTR. All PCR products were run in agarose gels and mapped to the position expected 
to let-7-directed Hmga2 cleavage. RNA was tested with two sets of SLA-RT primers: 
SLA-RT primers and SLA-8U-RT primers, which listed in the table. 8U-RT-PCR bands 
increased in 3’ adjacent region (highlighted with blue), the end in seed region 
(highlighted with red), and the 3’ complimentary pairing region (highlighted with red). 
The expected PCR size was marked with arrow at the left side of agarose gel. miRNA 
and target site seed region was highlighted with red. 
 
 
    A terminal U tail on RNA is known to serve as a ‘‘mark’’ for 5’- 3’ degradation. 
Certain types of mRNA, such as histone mRNA [133] and RNA interference cleavage 
products [132] are uridylated before degradation. This oligo U tract is recognized by the 
Lsm1–7 complex, which then appears to feed the transcript into the standard mRNA 
decay pathways [134]. 
   The next obvious question was which enzyme is responsible for uridylation after 
cleaved by miRNAs. We examined whether terminal uridylyl transferase (TUTase) might 
be responsible for the addition of an oligo U tail to RISC-generated RNA fragments. 
Knocking down TUTase 3 erases the accumulation of U-tract added fragments to 
background level. Knocking down TUTase 2 decreased uridylylized 5’ fragment only in 
the seed region (Figure 40) 
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     5’-  UGAGGUAGUAGGUUGUAUAGUU  -3’  
          |||||||    |||:||||: 
 3’–UCAGACCUCCAUCCAGAAACGUUCAGUU-5’ 
    |||||| 
 
 
HMGA2 Target 
 Regular Stem loop RT probe (5’–3’) 8U-Stem loop RT probe (5’–3’) 
U1 SL- AGTCTG SL- AAAAAAAAGTCTG 
C2  SL- GTCTGG  SL- AAAAAAAAGTCTGG 
A3   SL- TCTGGA   SL- AAAAAAAATCTGGA 
G4    SL- CTGGAG    SL- AAAAAAAACTGGAG 
A5 SL- TGGAGG SL- AAAAAAAATGGAGG 
C6      SL- GGAGGT      SL- AAAAAAAAGGAGGT 
C7 SL- GAGGTA SL- AAAAAAAAGAGGTA 
U8 SL- AGGTAG SL- AAAAAAAAAGGTAG 
C9         SL- GGTAGG         SL- AAAAAAAAGGTAGG 
C10 SL- GTAGGT SL- AAAAAAAAGTAGGT 
A11 SL- TAGGTC SL- AAAAAAAATAGGTC 
U12            SL- AGGTCT            SL- AAAAAAAAAGGTCT 
C13             SL- GGTCTT             SL- AAAAAAAAGGTCTT 
C14              SL- GTCTTT              SL- AAAAAAAAGTCTTT 
A15               SL- TCTTTG               SL- AAAAAAAATCTTTG 
G16                SL- CTTTGC                SL- AAAAAAAACTTTGC 
A17                 SL- TTTGCA                 SL- AAAAAAAATTTGCA 
B
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A18                  SL- TTGCAA                  SL- AAAAAAAATTGCAA 
A19                   SL- TGCAAG                   SL- AAAAAAAATGCAAG 
C20                    SL- GCAAGT                    SL- AAAAAAAAGCAAGT 
G21                     SL- CAAGTC                     SL- AAAAAAAACAAGTC 
U22                      SL- AAGTCA                      SL- AAAAAAAAAAGTCA 
U23                       SL- AGTCAA                       SL- AAAAAAAAAGTCAA 
C24                        SL- GTCAAT                        SL- AAAAAAAAGTCAAT 
A25                         SL- TCAATT                         SL- AAAAAAAATCAATT 
G26                          SL- CAATTA                          SL- AAAAAAAACAATTA 
U27                           SL- AATTAG                           SL- AAAAAAAAAATTAG 
U28                            SL- ATTAGT                            SL- AAAAAAAAATTAGT 
 
 
 
 
 
 
Figure 40. Effects of 3’ terminal TUTases on the addition of uridine residues to the 3’-
ends of let-7 cleaved mRNA fragments. (A) Effects of uridylation of target site 5# after 
treatment with TUTase2 siRNA and TUTase3 siRNA. The uridized sites at 3’ adjacent 
region (highlighted with blue), the end in seed region (highlighted with red), and the 3’ 
complimentary pairing region (highlighted with red) 3’ adjacent region (highlighted with 
blue), the end in seed region (highlighted with red), and the 3’ complimentary pairing 
region (highlighted with red). Knocking down TUTase 3 erases the accumulation of U-
tract added fragments to background level. Knocking down TUTase 2 decreased 
uridylylized 5’ fragment only in the seed region. The expected PCR size was marked 
with arrow at the left side of agarose gel. miRNA and target site seed region was 
highlighted with red. (B) The specific SL-RT primer and corresponding detected 
cleavage RNA fragment was illustrated in the table. (C) Western blotting analysis and 
(D) RT-PCR analysis of TUTase 2 and TUTase 3 after treatment with TUTase2 siRNA 
and TUTase3 siRNA. TUTase2 siRNA inhibited TUTase2 expression, and TUTase3 
siRNA inhibited TUTase3 expression.  
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    One possible explanation for observed miRNA cleavage pattern is that the retention of 
miRISC on its miRNA sites hampers mRNA 3’-5’ degradation and the 3’-5’ partially 
degraded mRNA fragments are further uridylylized by TUTase 3 recruited by miRISCs at 
2 and 3 nt of 3’ adjacent region. 
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     5’-  UGAGGUAGUAGGUUGUAUAGUU  -3’  
          |||||||    |||:||||: 
 3’–UCAGACCUCCAUCCAGAAACGUUCAGUU-5’ 
    |||||| 
 
 
HMGA2 Target 
 Regular Stem loop RT probe (5’–3’) 8U-Stem loop RT probe (5’–3’) 
U1 SL- AGTCTG SL- AAAAAAAAGTCTG 
C2  SL- GTCTGG  SL- AAAAAAAAGTCTGG 
A3   SL- TCTGGA   SL- AAAAAAAATCTGGA 
G4    SL- CTGGAG    SL- AAAAAAAACTGGAG 
A5 SL- TGGAGG SL- AAAAAAAATGGAGG 
C6      SL- GGAGGT      SL- AAAAAAAAGGAGGT 
C7 SL- GAGGTA SL- AAAAAAAAGAGGTA 
U8 SL- AGGTAG SL- AAAAAAAAAGGTAG 
C9         SL- GGTAGG         SL- AAAAAAAAGGTAGG 
C10 SL- GTAGGT SL- AAAAAAAAGTAGGT 
A11 SL- TAGGTC SL- AAAAAAAATAGGTC 
U12            SL- AGGTCT            SL- AAAAAAAAAGGTCT 
C13             SL- GGTCTT             SL- AAAAAAAAGGTCTT 
C14              SL- GTCTTT              SL- AAAAAAAAGTCTTT 
A15               SL- TCTTTG               SL- AAAAAAAATCTTTG 
G16                SL- CTTTGC                SL- AAAAAAAACTTTGC 
A17                 SL- TTTGCA                 SL- AAAAAAAATTTGCA 
A18                  SL- TTGCAA                  SL- AAAAAAAATTGCAA 
A19                   SL- TGCAAG                   SL- AAAAAAAATGCAAG 
C20                    SL- GCAAGT                    SL- AAAAAAAAGCAAGT 
G21                     SL- CAAGTC                     SL- AAAAAAAACAAGTC 
U22                      SL- AAGTCA                      SL- AAAAAAAAAAGTCA 
U23                       SL- AGTCAA                       SL- AAAAAAAAAGTCAA 
C24                        SL- GTCAAT                        SL- AAAAAAAAGTCAAT 
A25                         SL- TCAATT                         SL- AAAAAAAATCAATT 
G26                          SL- CAATTA                          SL- AAAAAAAACAATTA 
U27                           SL- AATTAG                           SL- AAAAAAAAAATTAG 
U28                            SL- ATTAGT                            SL- AAAAAAAAATTAGT 
 
Figure 41. Let-7 sponge inhibited let-7 directed uridylation and cleavage activity of 
Hmga2 mRNA. (A) let-7 sponge plasmid was constructed with GFP with two let-7 target 
sites in 3’UTR. After transfection in H1299 cells, the GFP expression was dramatically 
down-regulated compared with GFP expression plasmid, which indicated that the let-7 
sponge exhausted let-7 miRNA in H1299 cells. H1299 cells were co-transfected with 
RFP expression plasmid as transfection efficiency control. (B) After transfected with let-
7 sponge, the intensity of uridized PCR band was reduced compared to control group, 
which indicated the let-7 directed uridized acitivity was inhibited by let-7 sponge. The 
expected PCR size was marked with arrow at the left side of agarose gel. miRNA and 
C SLA-RT primers and 8U-SLA-RT primers list 
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target site seed region was highlighted with red. (C) The specific SL-RT primer and 8U-
SL-RT primers were illustrated in the table. 
     
    Looking for Hmga2 is the true target of let-7; we conducted let-7 depletion by 
transfected H1299 cells with let-7 sponge plasmid. When let-7 was depleted by let-7 
sponge, the cleavage and uridylation activity on target site 5# was inhibited, suggesting 
that the cleavage and uridylation activity is caused by let-7 (Figure 30).  
 
4.3.3 Cooperativity between adjacent target sites, blocking 3’-5’ degradation caused 
by the adjacent target sites 
    Based on our observations of le-7 targets on Hmga2, we hypothesized that when the 
two miRNA sites were close together, miRNA will work cooperatively. Several earlier 
studies have examined cooperative down-regulation via multiple miRNA target sites. 
Grimson et al. observed that siRNA cooperatively silenced a reporter bearing two target 
sites spaced 8-40 nt apart in 3’UTR. Expanding the distance to 56 nt disrupted the 
cooperative function [135].  
       We noticed one notable exception: when target site 6# and target site 7# are too 
close, in which the 5’ end of target site 7# is in the 3’ end of target site 6#, the cleavage 
activity is dramatically reduced (Figure 32-33). One possible explanation is that if the 
sites are too close there may be steric hindrance resulting in reduced function as we 
observed with the 9 base spacing versus a single site.  
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    To characterize how different target RNA context influence RISC-mediated target 
recognition and cleavage, we made plasmid PLJT214, which has two identical copies of 
let-7 target sequence inserted at the 3’ UTR of GFP reporter plasmid, 262 bp apart  
(Figure 42). Due to the identical target sequences were used in this plasmid constructs, 
the different patterns and effectiveness of cleavage for the copies in tandem can only be 
explained by the influence of mRNA context. The secondary structure was determined by 
using the Mfold algorithm. Target site T1 cleavage and uridylation activity are much 
efficient that target site T2, which may be explained by the position and secondary 
structure of target site T1 is more optimistically for let-7 than target site T2.  
  
 
Figure 42. Schematic representation of plasmid PLJT214 construction. Plasmid pLJT214 
contain dual miR-98 target sequences added to the 3’ UTR of GFP transcript.   
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     5’- UGAGGUAGUAAGU---UGUAUUGUU -3’  
         |||||||:||:    || | ||:| 
 3’–CUUAGCUCCAUCGUUUGCCGACUUUACGAG-5’ 
    |||||| 
 
 
PLJT214 Target 
 Regular Stem loop RT probe (5’–3’) 8U-Stem loop RT probe (5’–3’) 
C1 SL- GAATCG SL- GAATCG 
U2  SL- AATCGA  SL- AATCGA 
U3   SL- ATCGAG   SL- ATCGAG 
A4    SL- TCGAGG    SL- TCGAGG 
G5 SL- CGAGGT SL- CGAGGT 
C6      SL- GAGGTA      SL- GAGGTA 
U7 SL- AGGTAG SL- AGGTAG 
C8 SL- GGTAGC SL- GGTAGC 
C9         SL- GTAGCA         SL- GTAGCA 
A10 SL- TAGCAA SL- TAGCAA 
U11 SL- AGCAAA SL- AGCAAA 
C12            SL- GCAAAC            SL- GCAAAC 
G13             SL- CAAACG             SL- CAAACG 
U14              SL- AAACGG              SL- AAACGG 
U15               SL- AACGGC               SL- AACGGC 
U16                SL- ACGGCT                SL- ACGGCT 
G17                 SL- CGGCTG                 SL- CGGCTG 
C18                  SL- GGCTGA                  SL- GGCTGA 
C19                   SL- GCTGAA                   SL- GCTGAA 
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G20                    SL- CTGAAA                    SL- CTGAAA 
A21                     SL- TGAAAT                     SL- TGAAAT 
C22                      SL- GAAATG                      SL- GAAATG 
U23                       SL- AAATGC                       SL- AAATGC 
U24                        SL- AATGCT                        SL- AATGCT 
U25                         SL- ATGCTC                         SL- ATGCTC 
A26                          SL- TGCTCT                          SL- TGCTCT 
C27                           SL- GCTCTA                           SL- GCTCTA 
G28                            SL- CTCTAC                            SL- CTCTAC 
A29                             SL- TCTACG                             SL- TCTACG 
 
Figure 43. Cooperativity between two adjacent target sites. (A) Plasmid PLJT214 was 
cut by BglII to delete polyA tale, and cut by xhoI to delete target site T2. PLJT214, 
PLJT214 cut by BglII, and PLJT214 cut by xhoI were transfected into H1299 cells 
individually, and then SLA-RT-PCR detected the cleavage fragment and uridized 
fragment. The expected PCR size for detecting target site 1# cleavage fragment was 
labeled with T1, and for target site 2# was labeled with T2 with arrow at the left side of 
agarose gel. miRNA and target site seed region was highlighted with red. After cutting by 
xhoI, target site T2 cleavage and uridylation activity was totally gone, in addition, target 
site T1 cleavage and uridylation activity was also dramatically reduced. (B) The specific 
SL-RT primer and corresponding detected cleavage RNA fragment was illustrated in the 
table.  
 
   Furthermore, PLJT214 was cut by BglII to delete polyA tale, and cut by xhoI to delete 
target site T2.  After cutting by xhoI, target site T2 cleavage and uridylation activity was 
totally gone, in addition, target site T1 cleavage and uridylation activity was also 
dramatically reduced (Figure 43).  One possible explanation could be target site T1 and 
target site T2 function cooperatively.  
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4.4.4 Ago2 and GW182 are required for mediating miRNA targets cleavage and 
degradation  
    The existence of a link between the miRNA pathway and mRNA decay is supported by 
the observation that mammalian Agos, miRNAs and miRNA targets colocalize to 
cytoplasmic foci know as P-bodies. Following this endonucleolytic cleavage by Ago2, 
the resulting mRNA fragments are added oligo U by TUTase, which handed over to the 
general 5’-3’ mRNA-decay machinery. Strikingly, all proteins that function in the 5'-3' 
mRNA-decay pathway have now been shown to localize to P bodies. 
    GW182 have been shown to be associated with miRISC and required for miRNA-
mediated gene silencing. GW182 is localized to P bodies that are cytoplasmic messenger 
ribonucleoprotein (mRNP) aggregates containing mRNA decay factors, translational 
repressors and untranslated mRNAs. It is known that the oligo U tailored RNA fragments 
can be recognized by GW182 and subject to further degradation in P body.  
    We further tested if depletion of Ago2 and GW182 impair miRNA directed target 
cleavage and degradation. We knockdown Ago2 and GW182 in H1299 cells and carried 
out SLA-RT-PCR on target site 5# (Figure 44A). Ago 2 and GW182 was efficiently 
inhibited, which was confirmed by the western blotting (Figure 44B). When Ago2 and 
GW182 were depleted, Hmga2 target site 5# cleavage and degradation products 
decreased, which indicates that let-7 directed cleavage and uridylation activity are 
dependent on Ago2 and GW182.    
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     5’-  UGAGGUAGUAGGUUGUAUAGUU  -3’  
          |||||||    |||:||||: 
 3’–UCAGACCUCCAUCCAGAAACGUUCAGUU-5’ 
    |||||| 
 
 
HMGA2 Target 
 Regular Stem loop RT probe (5’–3’) 8U-Stem loop RT probe (5’–3’) 
U1 SL- AGTCTG SL- AAAAAAAAGTCTG 
C2  SL- GTCTGG  SL- AAAAAAAAGTCTGG 
A3   SL- TCTGGA   SL- AAAAAAAATCTGGA 
G4    SL- CTGGAG    SL- AAAAAAAACTGGAG 
A5 SL- TGGAGG SL- AAAAAAAATGGAGG 
C6      SL- GGAGGT      SL- AAAAAAAAGGAGGT 
C7 SL- GAGGTA SL- AAAAAAAAGAGGTA 
U8 SL- AGGTAG SL- AAAAAAAAAGGTAG 
C9         SL- GGTAGG         SL- AAAAAAAAGGTAGG 
C10 SL- GTAGGT SL- AAAAAAAAGTAGGT 
A11 SL- TAGGTC SL- AAAAAAAATAGGTC 
U12            SL- AGGTCT            SL- AAAAAAAAAGGTCT 
C13             SL- GGTCTT             SL- AAAAAAAAGGTCTT 
C14              SL- GTCTTT              SL- AAAAAAAAGTCTTT 
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A15               SL- TCTTTG               SL- AAAAAAAATCTTTG 
G16                SL- CTTTGC                SL- AAAAAAAACTTTGC 
A17                 SL- TTTGCA                 SL- AAAAAAAATTTGCA 
A18                  SL- TTGCAA                  SL- AAAAAAAATTGCAA 
A19                   SL- TGCAAG                   SL- AAAAAAAATGCAAG 
C20                    SL- GCAAGT                    SL- AAAAAAAAGCAAGT 
G21                     SL- CAAGTC                     SL- AAAAAAAACAAGTC 
U22                      SL- AAGTCA                      SL- AAAAAAAAAAGTCA 
U23                       SL- AGTCAA                       SL- AAAAAAAAAGTCAA 
C24                        SL- GTCAAT                        SL- AAAAAAAAGTCAAT 
A25                         SL- TCAATT                         SL- AAAAAAAATCAATT 
G26                          SL- CAATTA                          SL- AAAAAAAACAATTA 
U27                           SL- AATTAG                           SL- AAAAAAAAAATTAG 
U28                            SL- ATTAGT                            SL- AAAAAAAAATTAGT 
 
 
Figure 44. Knocking down Ago2 and GW182 inhibit Hmga2 cleavage and degradation 
activity directed by let-7 miRNA. (A) Agarose gel electrophoresis of SLA-RT-PCR 
products of target site 5# after Ago 2 and GW182 inhibition. The cleaved fragments 
product (detected by SLA-RT) and uridized fragments product (detected by 8U-SLA-RT) 
were inhibited after Ago2 inhibition and GW182 inhibition. The uridized region includes 
3’ adjacent region (highlighted with blue), the end in seed region (highlighted with red), 
and the 3’ complimentary pairing region (highlighted with red).  The expected PCR size 
was marked with arrow at the left side of agarose gel. miRNA and target site seed region 
was highlighted with red. (B) The specific SLA-RT primer and corresponding detected 
cleavage RNA fragment was illustrated in the table.  (C) Western blotting analysis of 
Ago2 and GW182 after H1299 treated with Ago2 siRNA and GW182 siRNA. Ago2 
siRNA inhibited Ago2 expression, and GW182 siRNA inhibited GW182 expression.  
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4.4.5 TUSC2 mRNA cleavage by miRNAs detected by SLA-RT-PCR 
     It has been confirmed that TUSC2 3’UTR played an important role in down-
regulating TUSC2 expression, which suggested miRNA may target on TUSC2 3’UTR. 
Target Scan software (http://www.targetscan.org/) predicted TUSC2 mRNA have 
hundreds of miRNA targets (Figure 45), which cannot be true and needs to be verified by 
SLA-RT-PCR in physiological conditions. Random SL-RT primer was designed first for 
screen the potential miRNA target on TUSC2, which has six random nucleotides at the 
3’end of SLA-RT-primer (Figure 46).  
 
 
Figure 45. miRNA targets on TUSC2 predicted by Target Scan Software 
(http://www.targetscan.org/). It predicted TUSC2 mRNA have hundreds of miRNA 
targets. miRNAs highlighted with purple predicted that target RNA have exact match to 
positions 2-8 of the mature miRNA (the seed + position 8) followed by an 'A' . miRNAs 
highlighted with red predicted that target RNA have an exact match to positions 2-8 of 
the mature miRNA. miRNAs highlighted with blue predicted that target RNA have an 
exact match to positions 2-7 of the mature miRNA (the seed) followed by an 'A'.  
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Figure 46.  SL-RT-PCR for screen miRNA targets cleavage fragments on TUSC2. SL-
RT-primer with six random nucleotides at 3’end was designed for screen cleavage 
fragments. 
 
    
 
 
 
 
 
 
 
 
 
Figure 47.  Random SL-RT-PCR detected cleavage fragments on TUSC2. (A) Agarose 
gel analysis of SL-RT-PCR product, the predicted miRNAs targets according to cleavage 
fragments size and PCR primers were labeled. (B) DNA sequence verification of 
cleavage fragments. The SL-RT primers were highlighted with blue. (C) Illustrations of 
miRNAs targeted at TUSC2. The PCR primers and miRNAs are mapped at 3’UTR 
according to the specific sizes.  
A B 
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   SL-RT-PCR with six random nucleotides at 3’end of SL-RT primer detected several 
cleavage fragments. According to fragments size and predicted potential targets, miR-98, 
miR-93, miR-637 and miR-23ab may direct TUSC2 cleavage. All cleavage fragments are 
verified by DNA sequence (Figure 47).  
   It was reported that squamous metaplasia and dysplasia express significantly lower 
levels of TUSC2 than normal and hyperplastic bronchial epithelia. SL-RT-PCR was used 
to screen different miRNA targets among different lung cell lines. The results showed 
that H1299 and H322 cells have miR-98 directed cleavage fragments, which cannot be 
detected in A549 cells and HBE cells (Figure 48). 
 
 
 
Figure 48.  SL-RT-PCR detection of miRNAs directed mRNA cleavage fragments in 
H1299, H322, A549 and HBEC cells. The predicted miRNAs targets according to 
cleavage fragments size and PCR primers were labeled. H1299 and H322 cells have miR-
98 directed cleavage fragments, which cannot be detected in A549 cells and HBE cells. 
98 
 
 
 
     Previous report confirmed an authentic miR-98 target on TUSC2 mRNA 3’ UTR and 
overexpressed miR-98 decreased TUSC2 mRNA level [86]. A collection of SLA-RT 
primers with 6 nt probe matching along TUSC2 miR-98 target sequence were designed to 
detect the accumulation of cleaved mRNA fragments around this site (Figure 49). 
Amplicon intensity from each RT-PCR reaction represented the relative abundance of 5’ 
RNA fragment detected by a unique SL-RT primer respectively. PCR amplicons were 
analyzed on agarose electrophoresis gels in the order of miR-98 target sequence at 3’-5’ 
direction. 5’ RNA fragment abundance around the endogenous TUSC2 miR-98 target 
were represented as intensity of PCR amplicons ranging from 232 bp to 200 bp (Figure 
49B). SLA-RT-PCR results showed the cleaved target sites are at C8, G31, A32, T33, 
G34 around miR-98 target sites. 
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                          TUSC2 mRNA
 
 3’–UCCUUAGCUCCAUCGUUUGCCGACUUUACGAGACUGAUCCCCAAUUUUCCCUUCA-5’ 
    |||||| 
 Regular Stem loop RT probe (5’–3’)
1  SL-AGGAAT 
2     SL-AATCGA 
3  SL-ATCGAG 
4       SL-TCGAGG 
5  SL-CGAGGT 
6  SL-GAGGTA 
7          SL-AGGTAG 
8  SL-GGTAGC
9  SL-GTAGCA
10             SL-TAGCAA
11              SL-AGCAAA
12               SL-GCAAAC
13                SL-CAAACG
14                 SL-AAACGG
15                  SL-AACGGC
16                   SL-ACGGCT
17                    SL-CGGCTG
18                     SL-GGCTGA
19                      SL-GCTGAA
20                       SL-CTGAAA
21                        SL-TGAAAT
22                         SL-GAAATG
23                          SL-AAATGC
24                           SL-AATGCT
25                            SL-ATGCTC
26                             SL-TGCTCT
27                              SL-GCTCTG
28                               SL-CTCTGA
29                                SL-TCTGAC
30                                 SL-CTGACT
31                                  SL-TGACTA
32                                   SL-GACTAG
33                                    SL-ACTAGG
34                                     SL-CTAGGG
35                                        SL-GGGGTT
36                                           SL-GTTAAA 
37                                                SL-AGGGAA 
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Figure 49.  SLA-RT-PCR detection of miR-98 directed TUSC2 cleavage fragments.  (A) 
SLA-RT primers design for detecting miR-98 directed cleavage fragments. (B) SLA-RT-
PCR products were run in agarose gels and mapped to the position expected to miR-98-
directed TUSC2 cleavage. The expected PCR size was marked with arrow at the left side 
of agarose gel. Predicted target site region were highlighted with red.  (C) DNA sequence 
confirmation of miR-98 directed cleavage fragments. The SL-RT primers were 
highlighted with red. 
B 
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    A collection of SLA-RT primers were designed to detect the accumulation of cleaved 
mRNA fragments around miR-637 target site (Figure 49A). SLA-RT-PCR results 
showed the cleaved target sites are at C6, C10 and T13 around miR-637 target sites. 
 
                          TUSC2 mRNA
 
 3’–UUGACCCCCAAGCCCCCAACCCCCCGUUGUCAAUCAACGUCAUCCCCCUAGUC-5’ 
           |||||| 
 Regular Stem loop RT probe (5’–3’)
1         SL-GGTTCG 
2 SL-GTTCGG 
3 SL-TTCGGG 
4 SL-CGGGGT
5 SL-GGGTTG
6 SL-GGTTGG
7 SL-GTTGGG
8                       SL-GGGGCA
9 SL-GGGCAA
10                          SL-GGCAAC
11                           SL-GCAACA
12 SL-CAACAG
13 SL-AACAGT
14 SL-ACAGTT
15 SL-CAGTTA
16 SL-AGTTAG
17 SL-GTTAGT
18                                   SL-TTAGTT
19 SL-TAGTTG
20 SL-AGTTGC
21                                     SL-GTTGCA
22                                      SL-TTGCAG
23                                       SL-TGCAGT
24                                        SL-GCAGTA
25                                         SL-CAGTAG
26                                          SL-AGTAGG 
27                                                  SL-GATCAG 
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Figure 50.  SLA-RT-PCR detection of miR-637 directed TUSC2 cleavage fragments.  
(A) SLA-RT primers design for detecting miR-637 directed cleavage fragments. (B) 
SLA-RT-PCR products were run in agarose gels and mapped to the position expected to 
miR-637-directed TUSC2 cleavage. The expected PCR size was marked with arrow at 
the left side of agarose gel. Predicted target site region were highlighted with red.  (C) 
DNA sequence confirmation of miR-637 directed cleavage fragments. The SL-RT 
primers sequences were highlighted with red. 
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    To further confirm the effects of these miRNAs on TUSC2 protein expression, we co- 
transfected H1299 cells TUSC2-3’UTR construct and miR-93 inhibitor, miR-98 inhibitor, 
miR-197 inhibitor, miR-637 inhibitor and miR-1207-5p inhibitor. As shown in Figure 51, 
miR-98 inhibitor and miR-93 inhibitor increase the TUSC2 expression. In summary, 
these results indicate that miR-93, miR-98, miR-637 down-regulate TUSC2 expression 
through directed TUSC2 mRNA cleavage and degradation.  
   
 
Figure 51.  Expression of TUSC2 after treated with miRNA inhibitors. H1299 cell was 
co-transfected with TUSC2 expression construct and miR-93 inhibitor, miR-98 inhibitor, 
miR-197 inhibitor, miR-637 inhibitor, miR-1207-5p inhibitor. MiR-93 inhibitor and miR-
98 inhibitor increase TUSC2 expression.  
 
4.5 Discussion 
    We have shown here that miRNA-directed endonucleolytic cleavage on mRNA was 
the initiation step of miRNA mediated gene silence. The cleaved RNA fragments were 
mostly oligouridylated at their 3’-termini and accumulated for RNA 5’ – 3’ decay later. 
The portion of RNA fragments escaped oligouridine modification were subject to 3’ – 5’ 
decay pathway and would be intercepted by other miRISCs stationed on their target sites 
at 5’ end. After shedding off exonucleases, RNA fragments were added with oligouridine 
at their 3’ termini. In this process, miRISC performed two activities - endonucleolytic 
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cleavage on mRNA targets and oligouridylation of cleaved 5’ RNA fragments. 
Oligouridylation of RNA fragments played important role in stabilizing RNA for 
accumulation and in converting RNA decay mode from 3’ - 5’ to 5’ - 3’. It would avoid 
the problematic degradation of mRNA at 3’- 5’ direction which processed opposite the 5’ 
- 3’ flow of translation apparatus. In case of mRNA in active translation, RNA fragment 
accumulation, other than degradation, gives time for translation to complete. This 
eliminated the possible adverse consequences of truncated proteins which might be 
produced with mRNA 3’ - 5’ decay pathway [127]. The delayed action on mRNA 
degradation desynchronized the lineage relationship of mRNA and protein abundance 
which contributed to the conflicted observation in many miRNA functionality tests [138, 
139]. 
    P-bodies are hubs for transient RNA species and played important role in miRNA 
mediated gene silence. All the components for miRNA machinery, including Agos, 
miRNA, GW182, Lsm1-7, XRN1, DCP1, CDP2, and Ccr4-Not complex can be found in 
P-bodies [90]. Blocking miRNA silencing pathways at any step prevented P-body 
formation, indicating that P bodies arise as a consequence of silencing [141-143]. The 
miRNA cleaved fragments are accumulated in oligouridylated form which could be 
recognized by cytoplasmic heptameric Lsm1-7 complex to facilitate the formation of P-
bodies. The accumulated RNA fragments in P-bodies are eventually degraded through 
RNA 5’ - 3’ decay pathway. Our results shed light on current knowledge of mature 
mRNA degradation initiated by Ccr4-Not complex-deadenylation pathway which is, in 
our opinion, too general to address tissue-specific mRNA half-lives. miRNA expression 
profiling revealed that miRNAs were specific to tissue differentiation, physiological and 
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pathogenic events [144, 145]. The micro-scale, leak-some and accumulative cleavage 
activities of miRNA on target transcripts make them primary candidates for tissue and 
event-specific mRNA half-life determinates in mammalian cells. The target site cleavage 
efficiency by miRNA could be determined by target mRNA context which influence the 
association and dissociation of the miRISC.  
    As currently available miRNA-target prediction algorithms do not take these issues 
into account, it is conceivable that many proposed miRNA-target interactions occur only 
in very specific contexts. Hence, the general applicability of proposed concepts of 
miRNA functions that are based on the genome-wide prediction of seed-based miRNA-
target interactions need to be assessed cautiously. Without knowing these context 
determinants, experimentalists face a difficult challenge. Where should they begin when 
seeking to understand the molecular mechanisms of phenotypes arising from miRNA 
knockdown or ectopic expression studies?  
   In this study, we tried to use the new developed SLA-RT-PCR method to identify the 
miRNA target sites at TUSC2 3’TUR. It was reported by Lee et al. [146] that miR-378 
could target TUSC2 3’UTR and repress the TUSC2 expression, leading to enhanced cell 
survival, tumor growth, and angiogenesis in human NSCLC cells. Another group in UT 
southwestern also reported that the 3’UTR of TUSC2 is a target of other miRNAs 
including miR-93, miR-98, and miR-197 [136]. Down-regulation of TUSC2 expression 
in both SCLC and NSCLC cell lines and primary tumors correlates with elevated miR-93 
and miR-197 expression [136].  
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     The SLA-RT-PCR verified that miR-98, miR-93 and miR-637 directed TUSC2 
cleaved and degraded. H1299 and H322 cells have miR-98 directed cleavage fragments, 
which cannot be detected in A549 cells and HBE cells. The level of TUSC2 3’UTR-
mediated down-regulation of TUSC2 gene and protein expression is significantly higher 
in lung cancer cells than in normal bronchial epithelial cells, which was might be 
attributable to miR-98 targets in 3’UTR.   
   Our studies elucidated the mechanism that mammalian miRNA regulating target 
mRNA degradation. These findings warrant further investigation to identify the precise 
miRNA targets in mammalians in endogenous context. Our findings also demonstrated 
that different miRNAs targeted at TUSC2 in different lung cell lines, which imply that 
these miRNA can be used as potential therapeutic targets by effectively blocking the 
interaction of miRNAs and TUSC2 targets to re-activate TUSC2 expression and restore 
its tumor suppression function in tumor cells. 
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